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ABSTRACT 
 Individuals afflicted with a pathogenic infection exhibit symptoms including lethargy, 
malaise, listlessness, loss of interest in social and environmental surroundings, and anorexia. 
Together, these symptoms comprise what is recognized as “sickness behavior.” Sickness 
behavior represents a conserved, motivational behavioral state that, with the induction of fever, 
serves to help an organism combat infection and ultimately survive. Long dismissed as an 
unavoidable consequence of the physiological changes resulting from pathogen-dependent 
immune activation, it is now well known that sickness behavior is a consequence of 
neuroimmune activation. Neuroimmunity serves as a bridge between the peripheral immune 
system and the central nervous system, acting to signal bi-directionally both centrally and 
humorally between these two systems. Proinflammatory cytokines, most often originating from 
innate immune cells, are the principle signaling molecules from the periphery to the brain. 
Sickness behavior is typically transient, resolving upon pathogen clearance. Exacerbated or 
unchecked proinflammation, such as occurs in chronic disease or autoimmune disorders, leads to 
maladaptive behaviors such as depression and anxiety. Neuroimmune activation often also 
causes cognitive impairments in addition to sickness, depressive or anxietal behaviors. It is 
widely recognized that non-infectious stimuli, such as ionizing radiation or hypoxia can activate 
the neuroimmune system and cause sickness behavior and other behaviors. This literature review 
focuses on the different ways activation of the neuroimmune system can occur, the inflammatory 
and behavioral consequences of its activation and some of the modulators of neuroimmune 
communication. Chapters 2 and 3 will provide evidence showing low dose ionizing radiation and 
chronic low-grade hypoxia can result in the display of typical neuroimmune-mediated behaviors, 
as well as other physiological changes. Taken together, these findings show that behavioral 
change can be induced by lower doses of ionizing radiation and hypoxia than have previously 
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been reported, and that neuroimmune signaling can occur where and when it was previously 
unknown to.  
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CHAPTER ONE
a
 
 
LITERATURE REVIEW 
 
I INFLAMMATION AND NEUROIMMUNE ACTIVATION 
 
Neuroimmunology as a field of study is relatively new with respect to the individual 
fields of neuroscience and immunology. However, that bi-directional communication can occur 
between the immune and nervous systems was known decades before the introduction of 
neuroimmunology as a term and field of study (1). Neuroimmunity is an important component of 
the innate immune system that acts to communicate peripheral immune status to the brain (2-3). 
In response to host infection, accessory immune cells (e.g. macrophages, dendritic cells) produce 
soluble mediators capable of signaling other immune cells, which then become activated and 
involved in fighting infection, often producing additional signaling molecules. The soluble 
mediators elicited by host infection are proinflammatory cytokines – small peptides involved in 
both intra- and intercellular communication, relay of information regarding development, tissue 
repair, hematopoiesis, inflammation and innate and adaptive immune responses (2,4). The brain 
has long been considered an immunologically privileged organ – that is to say foreign antigens 
within the brain parenchyma can avoid systemic immunological recognition – but the definition 
continues to be challenged as new findings arise. It is well recognized that the brain’s immune 
status can vary largely depending on brain region as well as natural processes such as aging 
(2,5). The brain contains its own immune cells, such as dendritic cells and specialized brain 
                                                          
a
 A portion of this chapter’s work has been accepted for publication: 
York J.M., Blevins N.A., Baynard T., Freund G.G., 2012. Mouse testing methods in psychoneuroimmunology. In: 
Walker J.M. (Ed.), Methods in Molecular Biology. In Press. Used with the kind permission of Springer Science and 
Business Media. 
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macrophages known as microglia. These brain-based immune cells respond to inflammatory 
stimuli by producing proinflammatory cytokines that can act on other immune cells and both 
neuronal and non-neuronal cells in the brain (2). While these actions are similar to those of the 
peripheral immune response, they differ in that molecules produced by activated brain immune 
cells do not lead to recruitment and invasion of peripheral immune cells into the parenchyma 
(2,5). Proinflammatory cytokines act on brain via several different routes. Initially it was 
discovered that peripheral proinflammatory cytokines, especially IL-1β, bind to afferent nerve 
fibers (e.g. vagus nerve), leading to increased vagal signaling to the brain. Cytokines may act on 
the brain by volume diffusion at sites outside the blood brain barrier (BBB), like the 
circumventricular organs (CVOs). Cytokines also exert their effect on the brain through saturable 
transport systems at the BBB, and perivascular macrophages and endothelial cells in brain 
vasculature possess receptors for IL-1β, and its binding causes production of prostaglandin E2, 
which ultimately induces the febrile response (2,6-7) Cytokines produced by peripheral innate 
immune cells signal their status to the central nervous system (CNS), which elicits a 
neuroendocrine response via the hypothalamic-pituitary-adrenal (HPA) axis (4,8). The activated 
HPA axis signals both peripherally to help regulate the immune response to infection, as well as 
centrally to elicit additional physiological effects (6-7,9). Major proinflammatory cytokines 
include interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) (2-4,6-
7). These cytokines have pleiotropic activity and functional redundancy. Proinflammatory 
cytokines can interact with a variety of cell types, including neurons, and induce a response 
specific to a cell type (2,4). Cytokines can also influence the production and response(s) to other 
cytokines – a result of an intertwining complex network of signaling pathways exerting different 
influences on each other (4). Proinflammatory cytokines rarely act alone. For example, IL-1β 
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secretion is often accompanied by the release of other proinflammatory cytokines (e.g. IL-6 and 
TNF-α), emphasizing their redundant function (10).  Upon activation of the HPA axis, 
adrenocorticotropic hormone (ACTH) is released from the anterior pituitary gland into the 
circulation where it binds cells of the adrenal cortex leading to the release of glucocorticoids 
(GCs) (7,9). GCs have multiple physiological functions, but critical to neuroimmunity they can 
inhibit proinflammatory cytokine production and inflammation, and can also act via negative 
feedback on the HPA axis to halt its activation (9,11-12). GCs also act on immune cells to 
increase the synthesis of anti-inflammatory cytokines such as interleukin-10 (IL-10), interleukin-
1 receptor antagonist (IL-1RA) and interleukin-1 receptor II (IL-1RII) (11,13). Together, the 
suppression/inhibition of proinflammatory cytokines and induction of anti-inflammatory 
cytokines by GCs leads to the eventual cessation of the inflammatory response and return to 
homeostasis in healthy individuals. 
 
II NEUROIMMUNE ACTIVATION-INDUCED BEHAVIORAL CHANGE 
 
A) SICKNESS BEHAVIOR 
Proinflammatory cytokine release in response to peripheral infection can induce 
behavioral change via a neuroimmune mechanism. Individuals afflicted with bacterial or viral 
infection, or treated with lipopolysaccharide (LPS; a component of gram negative bacterial cell 
walls and a potent activator of the neuroimmune system) show symptoms of lethargy, malaise, 
listlessness, loss of interest in social activity, and reduced food and water consumption. 
Together, these symptoms comprise what is referred to as “sickness behavior” (2-3,6,14). 
Sickness behaviors for many years were ignored by physicians as an unavoidable consequence of 
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the physiological changes caused by pathogen-dependent immune activation. Hart was among 
the first to propose behavioral change is not a consequence of the general debilitative effects of 
infection or a maladaptive response, but rather a motivational state with the function of 
potentiating the febrile response to infection, thus facilitating the recovery and survival of the 
host. This is supported by the fact that, in addition to fever, the behaviors associated with an 
infection are ubiquitous among most animal species (3,6-7). Hart’s seminal work in sickness 
behavior has led to an abundance of additional research toward understanding its role in host 
recovery/survival and the underlying mechanisms mediating behavioral change. 
Proinflammatory cytokines are principle inducers of sickness behavior, both those endogenously 
produced in response to immune stimulation, as well as those exogenously administered 
(peripherally or centrally) to experimental animals (2-3,6-7,14-16). Peripheral proinflammatory 
cytokine signaling to the brain induces central production of proinflammatory cytokines, and this 
can occur via the neural, humoral, or membrane transporter routes (2,6-7,14-16). Immune cells in 
the brain respond to much lower concentrations (100-1000 times lower) of cytokines than do 
those in the periphery, additional evidence that sickness behavior is a consequence of brain-
based immune activation (14). The initial discovery and subsequent investigation of sickness 
behavior and its neuroimmune-mediated mechanism(s) has led to the discovery and expansion of 
study to behaviors occurring after sickness behaviors have otherwise resolved.  
 
B) DEPRESSIVE-LIKE BEHAVIOR 
In individuals with chronic illnesses such as autoimmune disorders and cancer, the 
peripheral immune proinflammatory response can continue unabated. Interestingly, major 
depressive disorders are more commonly observed in patients with chronic inflammatory 
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diseases than in those without disease. Depression differs from sickness behavior in that it does 
not serve to assist the host in combating and recovering from an infection, but is considered a 
maladaptive consequence of unchecked proinflammatory signaling (2,17). In animals, 
“depressive-like” behaviors are studied. These behaviors mimic some of the features of clinical 
depression such as helplessness and anhedonia (2). Depressive-like behavior has been observed 
in rodent models at least as far back as the mid 1990s, when Yirmiya reported depressive-like 
behavior in rats following LPS administration (18). Importantly, depressive-like behavior is 
generally observed following recovery from the more acute sickness behavior. This is known to 
occur following initial sickness behavior responses to LPS (acute immune activator), and 
Bacillus Calmette-Guerin (chronic immune activator) (17,19-21). As with sickness behavior, 
proinflammatory cytokines can also induce depression, findings initially observed in human 
longitudinal studies where proinflammatory cytokines were administered as 
immunotherapeutics. In these studies all patients experienced sickness behavior following the 
first cytokine treatment, but after its resolution, up to one third of patients develop major 
depressive disorders (2,21). Further evidence for proinflammatory cytokine-induced depressive-
like behavior comes from rodent studies in which depressive-like behavior was induced by IL-1β 
treatment (2,22). Important to all studies investigating the impact of proinflammation on the 
development of depressive- or depressive-like behavior is to validate the behavior as depressive 
by pre-treating with antidepressant agents. In both animals and humans pretreatment with 
antidepressants before the proinflammatory cytokine treatment leads to reduced severity of 
depressed mood (23).  
 
 
 
 
6 
 
C) COGNITIVE BEHAVIOR 
 The proinflammatory response can also lead to cognitive impairment in the form of 
hippocampal-dependent memory deficits (2,10,24-27). Tests like contextual fear conditioning, 
related to hippocampal long-term potentiation, are affected by increased proinflammatory 
cytokine levels in the periphery and brain (2,10). Non-hippocampal-dependent memory functions 
remain unaffected following neuroimmune activation and proinflammatory cytokine release. It 
appears that IL-1β is the likely critical proinflammatory cytokine involved in memory deficits, as 
the dentate gyrus of the hippocampus possesses IL-1 receptors (24). This doesn’t rule out the 
involvement of other proinflammatory cytokines, as Pugh et al. indicated in their review on IL-
1β and memory function, TNF-α may have similar effects on memory impairment (10). The 
detrimental effects of proinflammation on cognition appear to be largely in the consolidation of 
memories, but not the learning process itself. An example of this comes from studies using the 
Morris water maze (MWM), in which intracerebroventricular (ICV) IL-1β treated rats were able 
to learn the escape task, but were impaired in their ability to recall the location of the escape 
platform (26). Recently, Goshen et al. published findings showing that IL-1β is actually required 
for learning and memory formation, and only when its levels are perturbed beyond a normal 
physiological range do hippocampal memory deficits occur (27-28). Il-1β’s effects on memory 
consolidation, both normal and impaired, can be reversed in either direction via treatment with 
IL-1RA (10,27-28). 
 
D) ANXIETY-LIKE BEHAVIOR 
 Similar to depression and depressive-like behavior, anxiety and anxiety-like behavior can 
be induced by proinflammatory cytokines in humans and animals, respectively (23). 
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Proinflammatory cytokine-induced development of anxiety-like behavior is less studied than 
sickness, depressive-like and cognitive behaviors. In one study aimed at determining whether 
anxiety-like behavior is a direct result of increased brain-based proinflammatory cytokine levels, 
Swiergiel and Dunn reported that LPS or IL-1β led to decreased open arm entries in an elevated 
plus maze (EPM) and decreased line crossings within the central area of an open field test (OFT) 
arena, both indicative of anxiety-like behavior. These decreases were also accompanied by 
significant reductions in arm entries in the EPM and total number of line crosses in the OFT, 
indicating sickness behavior may have clouded the effects of LPS and IL-1β on anxiety-like 
behavior (29). Anxiety-like behavior in rodents is largely studied in response to acute or chronic 
stress paradigms, which still involves the neuroimmune system in several ways.  
 
III STRESS AND NEUROIMMUNITY 
 
A) BASIC MECHANISM OF THE STRESS RESPONSE 
In addition to neuroimmune signaling, the physiological responses to acute and chronic 
psychological stress also utilize the bi-directional communication pathways between the CNS 
and the immune system, and can likewise impose alterations in neuroimmune signaling and 
response to infection. There are many definitions of psychological stress, but to define it in its 
simplest terms relevant to neuroimmunology, psychological stress occurs when events or 
environmental demands exceed an individual’s perceived ability to cope. Depending on the 
duration and course, psychological stress can affect the immune system in different ways (30). 
When an event is perceived as stressful, the HPA axis is activated via CRH release from the 
paraventricular nucleus (PVN) of the hypothalamus. An additional relevant system activated by 
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psychological stress is the sympathetic-adrenal-medullary (SAM) axis (30-32). Together these 
systems react to stress by releasing pituitary and adrenal hormones, which include ACTH, GCs, 
catecholamines (adrenaline and noradrenaline) and growth hormone, among others (30). These 
hormones have potent and often times multifunctional effects on the body’s physiology and the 
immune system is not excluded from the list of targets these hormones can act on (30-31). 
 
B) ACUTE STRESS 
There is evidence for both immunoenhancing, as well as immunosuppressive effects in 
response to psychological stress (33). Most immune cells express receptors for one or more of 
the hormones associated with the HPA and SAM axes, and the effects of receptor binding can act 
either directly, via binding to its analogous receptor, or indirectly through disruption of cytokine 
production (30). Immunoenhancing effects of stress are largely restricted to acute stress, where 
acute activation of the HPA axis and the sympathetic nervous system (SNS) during the “fight or 
flight response,” leads to increased leukocyte trafficking and enhancement of B cell immune 
responses. This is postulated to occur as a protective mechanism against wound infection 
following an aggressive encounter (32). Most acute psychological stress is associated with 
immunosuppression, or a shift to an anti-inflammatory phenotype. For example, in a study 
involving medical students taking an exam, acute stress led to a shift in CD4+ T helper cells (Th) 
from a Th1 (proinflammatory) to a Th2 (anti-inflammatory) phenotype. This may result in 
dysregulation of immune responses (34). Responsiveness to vaccines is also reduced by 
increasing levels of psychological stress, which is interpreted as a proxy for responses to 
infectious agents (31). Further evidence for psychological stress’ suppression of immune activity 
from animal studies has shown that stress causes reductions in vaccine response, enhances viral 
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and bacterial pathogenesis, alters autoimmune disease course and increases wound healing time. 
These effects are associated with decreased proinflammatory cytokine production and reduced 
immune cell trafficking (30-31).  
 
C) CHRONIC STRESS 
Chronic stress, on the other hand, can lead to increased proinflammation. In a model of 
social disruption, in which a dominant intruder was repeatedly introduced to a cage of mice (i.e. 
chronic psychological stress), submissive mice developed GC resistance in peripheral immune 
cells, rendering them insensitive to the effects of GCs (35). In general, chronically stressed 
individuals, as is seen in depression, may develop GC resistance and mount exacerbated 
peripheral immune responses to infectious pathogens. Indeed, Sheridan and colleagues showed 
that when mice are socially disrupted, it can lead to GC resistance. When the GC resistant mice 
were inoculated with influenza virus (intranasally) they were more likely to die as a result of 
increased inflammation, lung cellularity and pulmonary consolidation compared to influenza 
treated GC sensitive mice. In the same study, mice that were exposed to chronic/repeated 
restraint stress (16 h per day/4 days in a 50 mL conical tube) did not show GC resistance, 
indicating the perception of stress may have an impact on its physiological outcomes (36). The 
explanation posited for the GC resistance induced by the chronic stress of social disruption and 
not restraint is that with social stress, social hierarchy plays a role in the severity of GC 
resistance and the potential for wounding may modify the outcomes of social stress in order to be 
able mount an effective immune response (35-36). Taken together, the effects of chronic stress 
on resistance to GCs may lend evidence to the exacerbated inflammatory responses observed in 
depressed individuals, who often report high levels of stress (37). 
 
 
10 
 
IV NEUROIMMUNE AND BEHAVIORAL EFFECTS OF IONIZING RADIATION 
EXPOSURE 
 
A) IONIZING RADIATION FUNDAMENTALS 
Non-infectious stimuli are capable of activating the neuroimmune system. This is well 
established in studies investigating the inflammatory effects hypoxia and ionizing radiation 
exposure. Ionizing radiation (IR) can activate of the neuroimmune system and inflammatory 
responses. IR sources include therapeutic (e.g. cancer radiotherapy), space and natural 
(terrestrial) background. Several different types of radiation exist. The most commonly used in 
both research and clinical settings are x-rays, gamma rays and protons. X- and gamma-rays are 
both photon radiation, and deposit their energy relatively close to the surface of a tissue (0.5-4 
cm depth). Protons, however, are becoming more popular due to their lack of tissue damage to 
surrounding (non-targeted) tissues. Protons deposit their energy near the end of their particle 
track (20-30 cm depth) (38). In biological tissues, units of radiation are represented as absorbed 
dose, defined as the energy deposited in the tissue. Units representing the absorbed dose of 
radiation are gray (Gy) and radioactivity absorbed dose (rad). Gray is the SI unit, and is the 
amount of radiation needed to deposit 1 joule (J) of energy in 1 kg of tissue (J/kg). Rad 
represents the amount of radiation required to deposit 0.01 J of energy in 1 kg of tissue, therefore 
100 rad = 1 Gy (39). IR, both therapeutic and non-therapeutic, can cause irreparable damage to 
cellular components, especially DNA. Evidence exists indicating that the nucleus is the most 
radiosensitive organelle within the cell, with doses in the range of 1.5 Gy required to cause 
lethality, but doses up to 250 Gy delivered to the cytoplasm can have little or no effect (40). 
Acute radiation syndrome (ARS; also known as radiation toxicity or radiation sickness) results 
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from irradiation of all or most of the body by a high dose of IR over a relatively short time 
(minutes). The three classic ARS syndromes are, in order of required induction dose (a) bone 
marrow syndrome (also known as hematopoietic syndrome; requires ~0.7-10 Gy) (b) 
gastrointestinal syndrome (requires > 10 Gy) and (c) cardiovascular/CNS syndrome (requires > 
50 Gy). Depending on the particular syndrome, symptoms will vary, with increasing severity 
with increasing dose. ARS is further broken down to 4 stages: (a) prodromal stage (nausea-
vomiting-diarrhea (NVD) stage), (b) latent stage, (c) manifest illness stage and (d) recovery or 
death stage. The prodromal stage can last anywhere from minutes to days, while the latent and 
manifest illness stage last between hours and weeks, and those exposed to IR who don’t recover 
typically die within several months (41-42). High dose rate (HDR) and low dose rate (LDR) 
represent how rapidly radiation is delivered, and generally are relative terms to each other. 
Importantly though, HDR IR is more biologically effective than LDR IR (i.e. severity of ARS 
increases) (42). IR exposure induces damage on the cellular level through direct and indirect 
effects. Direct effects result when DNA damage is caused by the direct ionization of DNA 
molecules by IR. Indirect damage results from radiation’s ionization of atoms in the cell, which 
leave ions and free electrons behind that bind to other molecules in the cell forming reactive 
species, which are much longer lived than ions (on the magnitude of 10,000x longer). For 
example, ions and/or free electrons react with oxygen to form reactive oxygen species (ROS) 
(40). Biological effects of radiation are characterized as either stochastic or deterministic. 
Stochastic effects (e.g. cancer) are the principle health risk from IR at doses < 100 mGy. 
Deterministic effects (also known as “tissue reactions”) result from very high IR doses that 
predominantly result in cell killing. IR doses accumulated in a protracted manner elicit lesser 
biological effects than those received in a short period of time (42). 
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B) NEUROIMMUNE EFFECTS OF IONIZING RADIATION 
In terms of neuroimmune effects, it is well established that ionizing radiation leads to 
production and release of proinflammatory cytokines, adenosine triphosphate (ATP) and 
generation of reactive oxygen species (ROS) (43-45) . IR is capable of inducing expression and 
binding activity of nuclear factor κB (NFκB).  NFκB is a transcriptional regulator of several gene 
products, including proinflammatory cytokines (6,43). This data supports other studies showing 
that IR increases gene expression of proinflammatory cytokines including TNF-α, Il-1β, IL-6 and 
IL-1RA (43,46-47). The brain is not spared from IR-induced inflammation. Studies have 
confirmed this, via direct CNS as well as whole body irradiation (48). Direct evidence for 
neuroimmune system activation by IR is provided by Marquette et al., who showed when rats 
were partial-body irradiated with shielded heads, IL-1β, TNF-α and IL-6 levels were 
significantly increased in the brain 6 h post-IR exposure. Similar to a peripheral infection, the 
vagus nerve was found to be responsible for signaling the peripheral immune status to the brain, 
and vagotomy prevented the increase in these brain-based proinflammatory cytokines (49). 
 
C) BEHAVIORAL EFFECTS OF IONIZING RADIATION 
To date, very few reports exist describing behavioral change following IR exposure. In 
the 1970s and 80s, Bogo published findings showing that monkeys exposed to 10 Gy IR at dose 
rates of 0.3, 0.8 and 1.8 Gy/min had impaired performance in memory and cognition tasks in 
81% of the 1.8 Gy/min group, but only 7% experienced impairment in the 0.3 Gy/min group. 
Additionally, as task complexity increased, it resulted in greater behavioral impairment. From 
these experiments, it was estimated that < 3 Gy was the effective dose to induce performance 
deficits (50). Around the same time, IR exposures of 0.25 Gy were found to induce rodent 
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conditioned taste aversion (50). More recent behavioral studies have yielded results showing 
exposure to 3 Gy IR was sufficient to cause a decrease in latency to fall from the rod in a rotorod 
test, and this dose also caused loss of acoustic startle habituation (51). Lower doses used in 
another study (0.1, 0.5 or 2 Gy) did not cause significant differences in open field, rotarod or 
acoustic startle habituation, compared to sham irradiated controls (52). A 5 Gy dose of IR was 
shown to decrease performance accuracy and reliability in 3 tests of cognitive behavior 
(psychomotor speed, discrimination accuracy and inhibitory control in a level pressing test) (53). 
 
V NEUROIMMUNE AND BEHAVIORAL EFFECTS OF HYPOXIC EXPOSURE  
 
A) HYPOXIA FUNDAMENTALS 
Individuals with asthma, chronic obstructive pulmonary disease (COPD), heart failure, 
sleep apnea, exposure to high altitude and acute hypotension (as a consequence of stroke or 
trauma) often experience acute hypoxia (54-58). The brain uses approximately 20% of the 
body’s resting oxygen, but only accounts for about 2% of an individual’s body weight (59). 
Because of its high energetic demand, the brain is exceptionally sensitive to changes in oxygen 
concentration. In the face of a hypoxic episode, the brain will turn off non-essential brain 
functions and maintain functions critical for survival. Essential functions, like respiration may 
undergo a biphasic response, in which the organism initially adapts by attempting to enhance 
oxygen supply/reduce consumption, before eventually reducing respiratory rate to conserve 
oxygen, especially in the case of prolonged hypoxia (60-61). In response to hypoxic conditions, 
blood flow is increased almost two fold to the brain, and is mediated by the brainstem (61).  
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B) NEUROIMMUNE AND BEHAVIORAL EFFECTS OF ACUTE HYPOXIA 
Hypoxia exposure can result in proinflammation (62). Hypoxia causes macrophages to 
produce proinflammatory cytokines. These proinflammatory cytokines, which are also produced 
in response to hypoxia/ischemia may be involved in hypoxia-related brain damage. Hypoxia 
leads to the release of cellular ATP and generation of ROS (63-64). Hematologically, hypoxia 
leads to increased renal erythropoietin, leading to increased red blood cells (RBCs), thereby 
increasing oxygen carrying capacity (65). Intermittent hypoxic episodes, such as with obstructive 
sleep apnea (OSA) patients, express increased levels of inflammatory and oxidative stress 
molecular markers (66). Mice exposed to a similar intermittent pattern of hypoxia exhibit 
inflammation, neurodegeneration and deficits in spatial learning (66). Acute hypoxic exposure 
causes a significant elevation of IL-1β mRNA expression in the brain, which is followed by 
increased IL-1RA and IL-1R2 2 h later. Acute hypoxia-induced sickness behaviors were shown 
to be mediated by the upregulated IL-1β, and could be prevented by caspase-1 inhibition and/or 
IL-1 receptor antagonism, (67). Leptin is a pleiotropic adipokine largely responsible for appetite 
regulation and energy regulation, and is involved in the recovery from acute hypoxia. In their 
study, Sherry et al. showed that leptin was required for timely up-regulation of IL-1RA, which is 
necessary to counter the effects of hypoxia-induced IL-1β (68). 
 
C) NEUROIMMUNE AND BEHAVIORAL EFFECTS OF CHRONIC HYPOXIA 
Chronic hypoxia is also related to proinflammation. Very few studies have been 
conducted investigating chronic hypoxia’s direct effects on inducing proinflammation. However, 
studies utilizing at disease states in which chronic hypoxia is a main component are useful 
toward uncovering hypoxia-induced proinflammation. Chronic obstructive pulmonary disease 
 
 
15 
 
(COPD) is a respiratory condition characterized by chronic hypoxia (69-71). COPD is associated 
with increased systemic inflammation, indicated by increased IL-6, IL-8 and TNF-α  (69-71). 
Interestingly, there is little information published regarding systemic levels of IL-1β in COPD 
patients. One study showed IL-1β is potently upregulated and secreted in the carotid body of rats 
exposed to chronic hypoxia. IL-1β is thought to be involved in altering subsequent vascular 
response to long-term reduced oxygen (72). No neuroimmune mediated behaviors have been 
shown to be affected by chronic hypoxia, although there are some reports indicating that OSA, a 
chronically intermittent hypoxic state, can lead to cognitive impairments. These impairments, 
however, could be associated with excessive sleepiness, which the authors noted in their study 
(69). Obesity, to a lesser degree than COPD, is disease associated with low-grade chronic 
hypoxia. However, while systemic hypoxia may occur, it likely isn’t until respiratory function 
becomes impaired (due to body mass) that true systemic chronic hypoxia takes effect. Chronic 
hypoxia does occur in obese adipose tissue, which also typically expresses a low level of chronic 
inflammation as well (73-74). 
 
VI  MOUSE TESTING METHODS IN PSYCHONEUROIMMUNOLOGY: AN 
OVERVIEW OF HOW TO MEASURE SICKNESS, DEPRESSIVE/ANXIETAL, 
COGNITIVE AND PHYSICAL ACTIVITY BEHAVIORS 
 
A) INTRODUCTION 
Since its inception as an interdisciplinary field of science in the 1970’s, behavior has 
been an integral part of psychoneuroimmunology (PNI). Indeed, PNI is generally defined as the 
study of the interactions between behavior, neural, immune and endocrine system functions (75-
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76). Behavior can be, and is largely, used to assess whether a particular stimuli or experimental 
treatment has the potential to activate the neuroimmune system (75-76). An important concept to 
recognize in PNI is the bi-directionality that exists between the nervous system and the immune 
system (76). This is to say that both neural-to-immune and immune-to-neural signaling can and 
do occur. Shared pathways exist between the nervous and immune systems that use a repertoire 
of signaling molecules such as cytokines and neurotransmitters (77) that are capable of 
interacting with both immune and nervous system cells. These bioactives can convey the state of 
peripheral immunity to the neuroimmune system, communicate the status of neuroimmunity to 
the peripheral immune system (14,77-78) and provide immuno-activating and deactivating 
signals to immune cells throughout the body (6). 
 Observation of innate immune-mediated behavioral change (immunobehaviors) is largely 
used as a method of measuring neuroimmune activation in response to pathogenic insult of 
infectious (6) or non-infectious (67) etiology. Sickness behavior, in a classical sense, is a set of 
coordinated behavioral changes in response to immune stimulation aimed at conserving and 
redirecting body energy stores toward combating illness and promoting recovery (7). 
Immunobehaviors are best known for their manifestation in association with bacterial infection 
(7), but materialize in spectrum of conditions and diseases including cancer (7), autoimmune 
disorders (79), wounding (80), depression (2) and obesity (81). In any circumstance in which the 
innate immune system is activated, peripheral inflammatory mediators can impact the brain, 
altering normal function and causing symptoms of illness/loss of well-being (7,14). Typical 
sickness behavior symptoms include reduction in food intake, lethargy, malaise, loss of interest 
in social and/or environmental surroundings, changes in sleep patterns and impaired cognition 
(2,7,14). Furthermore, continued or dysregulated activation of the neuroimmune system can 
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progress beyond acute sickness symptoms and transition to behaviors observed in the anxious or 
depressed (2). Fatigue is often a lingering complication of neuroimmune activation (6), and can 
present as purely mental or physical or (most commonly) in a combinational form (82). In 
rodents, exercise behaviors like spontaneous wheel running (83) are helping to unravel the 
complex biology of physical fatigue while tests examining memory formation (learning) and 
memory recall are being used to explore mental fatigue (84).  
 Finally, immunobehaviors are a powerful indicator of neuroimmune status offering 
insight into the pro-inflammatory milieu of the brain. Altered behavior manifests prior to 
detectable changes in brain-based bioactives and lingers past their resolution. Such conditions 
indicate that the brain is very sensitive to small perturbations and that traditional chemical 
bioassays are often not sensitive enough or appropriately targeted to detect brain-based 
dysfunction at the molecular level. Hence, use of behavioral testing provides highly sensitive and 
phenomenologically relevant information in regard to brain function but lacks significant 
specificity from a mechanistic standpoint. This is either due to an evolution-derived paucity of 
immunobehavioral phenotypes or a current knowledge/technical deficiency in the ability to parse 
such behaviors into a multitude of biologically relevant subsets. In this review, methods for 
measuring sickness, depressive/anxietal, cognitive and physical activity behaviors in mice are 
described. The tests were chosen based on common usage and validated outcomes.  
 
B) PRE-EXPERIMENTAL CONSIDERATIONS 
Behavior is a valuable tool for gauging the presence, severity and duration of innate 
immune activation. Prior to behavioral experimentation, preparatory procedures are required so 
that meaningful and repeatable results can be obtained. Mice, like most animals used for 
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laboratory research, are responsive to the environment. Consistency and reproducibility of results 
as in any field of science is dependent on the decisions made and precautions taken before 
initiation of testing. While the following does not account for every possible pre-experimental 
housing and husbandry scenario, it does seek to articulate and define significant areas of pre-
experimental bias. Every animal facility, like every laboratory, is unique with differences 
obvious and subtle. Standardizing and controlling for clear confounds related to mouse strain, 
gender and scientific model; and maintaining housing and husbandry practices that support 
animal behavioral well-being and physical health are key. In addition, the following is not 
intended to be an absolute guide for “correct” mouse immunobehavioral experimentation, for it 
is critical that the investigator identify, develop and hone best practice related to the particular 
area of study with a firm eye on federal laboratory animal regulations and local institutional rules 
and guidelines. 
 
1. Model and strain choice 
 A first consideration should be the animal model and strain chosen. The vast majority of 
PNI behavioral testing utilizes rats and mice. Porcine models have been used (85), as have other 
types of rodents, especially prairie voles (86). Mice are especially useful in neuroimmune and 
immunobehavioral research due to their ability to reproduce and mature rapidly and the relative 
ease to which genetic modification can be applied through mutational, transgenic and knockout 
approaches (87). Different behavioral phenotypes exist between strains. Therefore, it is important 
to be aware of and control for potential inter-strain and inter-substrain variances (87), as well as 
intra-strain variation between mice raised/housed by disparate commercial venders and 
institutional facilities. Furthermore, genetically altered/modified mice are especially prone to 
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immunobehavioral alteration and should be selected with such in mind. With genetically 
altered/modified mice, diligent baseline testing in comparison to wild type animals is essential to 
ensure the behavior noted is causative (i.e. due to knockout of a specific target gene) and not a 
result of an unexpected consequence (e.g. saccharin preference anomalies in leptin unresponsive 
mice (db/db and ob/ob) related to the importance of leptin to sweet taste and not due to a type 2 
diabetes phenotype (88)).  
 
2. Gender 
 Depending on strain, genetic alteration/modification and behavioral test, male and female 
mice will perform differently. For example, in the elevated plus maze (EPM) females exhibit less 
general activity (89). When female mice are compared to male mice in a freely explorable open 
field arena, female mice are less active, are less willing to leave their home cage to enter the 
open field and are less likely to explore the open field (90). Female mice generally run for 
shorter distances in a voluntary wheel running paradigm than male mice (91), and will run 
different distances depending on their current state in the oestrus cycle (92). Thus, regardless of 
identical housing and husbandry practices, care must be taken in mixing genders during 
behavioral testing. Such care can be especially frustrating when using genetically 
altered/modified animals due to in-house breeding deficiencies and difficulty in acquiring 
adequate numbers of similarly aged animals from commercial suppliers.  
 
3. Age 
 Natural aging effects decreases in immune functioning with individual variation in 
severity depending on factors such as life-long physiological stressor exposure (93). It comes 
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with little surprise then, that neuroimmune-based behavior can also be affected by age. While 
sickness behavior appears beneficial to young mice, it may be maladaptive in older mice (94). 
Age can also negatively impact physical activity where aged mice run less (95). Young mice 
present difficulty in running analyses as well due to progressive increases in distance traveled 
(96). Investigators should be aware of potential differences arising from non-age-matched 
experimental mice and older mice reared under disparate conditions. 
 
4. Transportation 
 Environmental factors play a significant role in how mice behave and respond to 
neuroimmune stimuli and immunobehavioral treatments. Mice should be allowed a transition 
phase to acclimatize to a new environment. Whether this is the procedure experimentation room 
itself (97-98), or the housing room following arrival from a commercial supplier or other outside 
source (97,99). Biochemically, transportation stress increases plasma corticosterone levels in 
mice regardless of transport duration, and up to 48 h of acclimation is required for corticosterone 
to return to pre-transportation values (98). Behavioral change in response to transport has been 
shown to persist for 4 days (29), and body weight reduction returns to pre-transport levels within 
4 days (97,99). Therefore, a period of 5 days of acclimatization is generally required as a 
minimum for mice undergoing behavioral testing following off-site transportation (99). A 
minimum of 24 h of acclimatization time following on-site transportation (i.e. between housing 
and experimental rooms) should also be utilized (99). These are minimum time 
recommendations for acclimatization. Longer times may be necessary depending on the type of 
mice used, the duration of transport and the breadth of difference between initial and relocated 
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environmental conditions (97,99). As with any laboratory test, validation studies are 
recommended to confirm pre-experimental choice decisions.  
 
5. Light cycle 
 Alteration of light cycle has been shown to affect natural murine behavioral patterns (99), 
as well as neuroimmune behavior (e.g. anxiety) (100). Mice are under control of a genetically-
driven circadian clock that serves to regulate physiological and behavioral processes in a diurnal 
fashion (101). Therefore, it is important to ensure that experimental rooms have a similar light 
cycle to the housing room. In addition, it is advisable to initiate behavioral experiments at the 
same time of “day” especially when performing repeat testing. Mice are active at night, and, for 
the majority of testing, should be tested during the dark cycle. Reverse light cycle housing is 
beneficial so as not to put undue burden on personnel performing the behavioral tests. Mice also 
are crepuscular (102), with heightened activity during the early (dusk) and late (dawn) 
components of the light cycle dark phase and should be tested during these peak activity times. 
Methods for determining the timing of these active periods are described in the locomotor 
activity section. 
 
6. Temperature/Humidity 
 Temperature should be largely similar across animal housing facilities, as it is federally 
regulated by the Office of Laboratory Animal Welfare (OLAW) in the United States (103). 
According to the Guide for the Care and Use of Laboratory Animals, mice should be housed in a 
room/environment with temperatures ranging from 68-79 °F (20-26 °C) (34). Mice show 
neuroimmune and behavioral sensitivity to both heat- (104) and cold-stress (105) indicating the 
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potential for altered behaviors with temperature fluctuations. Relative humidity should also be 
maintained at similar levels across animal housing facilities, and the Guide for the Care and Use 
of Laboratory Animals indicates a range of 30-70%. Cage style, construction, bedding and 
enrichment materials as well as housing density affect temperature and humidity within the cage 
microenvironment (103). It is therefore important to recognize that room temperature and 
humidity may not necessarily reflect intra-cage temperature and humidity, depending on housing 
factors. 
 
7. Noise 
 Noise also has the potential to activate neuroimmune signaling pathways and alter 
behavior, as bell ringing (106) and noise produced by vacuuming (107) have been shown to 
stress laboratory mice as evidenced by activation of the hypothalamic-pituitary-adrenal (HPA) 
axis (9,108). White noise generators that create a constant background have been shown to 
reduce behavioral response to sudden loud noise (109). 
 
8. Odors 
 Mice use odors for communication, marking territory and in individual and group 
recognition signaling (99). In addition to using patterns of urine deposition for communication 
mice also produce specialized odors via several glandular secretions (99). There is also evidence 
that neuroimmune activation can alter odor production and that odors can induce behavioral 
change. When mice are administered the classical neuroimmune activator lipopolysaccharide 
(LPS) they generate olfactory cues to indicate that they may have a transmissible pathogen 
causing healthy cage mates to socially withdraw from the sick mouse (110). This phenomenon is 
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also seen in healthy mice housed with tumor-bearing cage mates (111). Finally, exposure to 
foreign/strange odors (e.g. human associated odors) can result in stress responses (99). 
Unfortunately, no specific research has been performed examining the duration of olfactory 
stress responses in mice, nor is there an identified acclimation or exhaustion time for evocative 
scents. It should also go without mention that eliminating as many olfactory cues within rooms, 
cages and on experimental apparatuses (e.g. through use of 70% v/v ethanol) is best practice. 
Mouse handler odors (i.e. perfumes and predator scents (e.g. feline)) should be minimized and/or 
eliminated. 
 
9. Handling 
 Physical handling of mice is a well studied modifier of mouse physiology and behavior 
(112). Therefore, it is advisable to handle mice at least daily so as to acclimate them to their 
human researchers and to physical contact. With this, mice will be more likely to appropriately 
and consistently respond to experimental treatment and have a reduced opportunity to succumb 
to handling stress which can elevate blood corticosterone (113).The handling method used, 
however, appears important. Mice respond to handling more readily when removed from their 
cage passively, such as with a tube or cupped hands, as opposed to the more traditional removal 
by grasping the base of the tail with the thumb and forefinger or soft forceps (114). Hurst and 
West noted that mice develop a consistent response (measured as voluntary interaction with 
handlers) by the ninth day of single 60 s handling sessions, regardless whether the mice were 
picked up by grasping the tail base or allowed to enter a tube or cupped hands before handling 
(114). Of note, mice picked up by the base of the tail had a lower level of voluntary interaction, 
compared to tube and cupping methods (114). Furthermore, when investigators acclimated mice 
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by removing mice from their cages with tubes or cupped hands, the mice were not aversive to 
scruff restraint, whereas those removed via tail base grasping showed increased distress when 
scruffed (114). As such, a period of at least 9-10 days of daily handling appears sufficient to 
ensure a consistent and non-aversive response in mice. If injections are a necessary component 
of a behavioral experiment, a passive method of mouse cage removal appears best. 
 
10. Housing method/environmental enrichment 
 Mice are social animals and should be housed as often as possible with other mice (103). 
Several studies have investigated the impact that individual housing/social isolation has on 
neuroimmunity and immunobehaviors, and social isolation induces aggression in male mice 
(115). Individually housed male mice also appear more prone to developing anxiety- and 
depressive-like behaviors following exposure to unpredictable chronic mild stress (116) despite 
their increased propensity to explore (90,98). Group housed mice order themselves into a social 
hierarchy, with 1-2 dominant mice and several subordinate mice. Subordinates as well as 
dominant mice show similar exploratory levels in an open field context (90) but this seems 
dependent on the relatedness of the group-housed mice, for an introduced non-sibling dominant 
intruder mouse evokes social stress and immune cell glucocorticoid resistance in the group-
housed mice (35). Therefore, housing mice in groups at a density of one 25-30 g mouse per 77.4-
96.7 cm
2
 of cage floor area by 12.7 cm of cage ceiling height appears advantageous (103).  
Interestingly, a clean cage environment (99,117) and novel cage construction materials can 
reduce mouse welfare and induce aberrant behaviors (99,103). Introduction to a clean/novel cage 
has been shown to increase plasma corticosterone in mice and to increase physical activity within 
the first 24 h of exposure. Metal cages, as opposed to more commonly used plastic cages (103), 
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are colder to the touch, more conducive to noise generation and less permeable to light (99,103). 
Additionally, the use of solid flooring with absorbent bedding is recommended by most 
institutional care and use committees, as well as federal regulatory bodies, because wire mesh 
flooring can lead to paw injury (103) that can confound behavioral experiments involving the 
innate immune system (6).  
Environmental enrichment is thought to enhance mouse well-being by providing motor 
and sensory stimulation. Environmental enrichment may include nesting material, structures 
and/or shelters within the cage (103). Lack of environmental enrichment dampens mouse 
reactivity and alertness in many behavioral tests (118). Environmental enrichment is, however, 
somewhat strain-dependent because the loss of reactivity and alertness noted above was observed 
in BALB/c mice but not seen in C57BL/6 mice. In fact, Van de Weerd et al. concluded that male 
BALB/c mice housed in enriched environments were anxious (118). Olsson and Dahlborn noted 
simply changing the barren cage environment by placing objects within it does not necessarily 
lead to “enrichment” (119). Instead, it is important to observe what, how and when behavioral 
and physiological changes occur in the animal, and if these changes result in long-term improved 
health and well being of the animal. Some “environmental enrichers” are felt to result in 
increased stress and anxiety (118,119). Thus, the environment within the cage may be as 
important as the environment in which the cage is housed in when establishing appropriate pre-
experimental procedures. 
 
C) SICKNESS BEHAVIORS 
Sickness behavior is classically defined as the non-specific set of symptoms associated 
with the body’s response to innate immune challenge (6). Symptoms of sickness behavior 
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include anorexia, fatigue, malaise, reduced locomotor activity, loss of interest in environmental 
and social surroundings and disappearance of body-care activity (6,120). These changes occur in 
response to brain-based increases in the proinflammatory cytokines interleukin-1β (IL-1β) and 
tumor necrosis factor-α (TNF-α), resulting in changes in the motivational state of an organism 
(2,6). Sick individuals also experience psychological symptoms such as anxiety and depression, 
and cognitive deficits such as learning and memory loss (discussed in later sections). Frequently 
used methods for quantifying sickness behavior include social exploratory activity (121), 
locomotor activity (14,122), food disappearance (14,122) and rotarod testing (51,123). 
 
1. Social exploration of a novel juvenile 
 The paradigm of social exploration appears to have evolved from work done by Thor and 
Holloway showing that adult laboratory rats actively investigate and form social memories of 
conspecifics (124), principally via ano-genital sniffing, nosing, mutual grooming and close 
following (125). Rodents also do not show behavioral habituation during social investigation 
provided the conspecific juvenile is novel at each presentation into the home cage of the adult 
(126). Furthermore, adult male rats do not exhibit aggression towards prepubertal male juveniles 
but do toward un-related postpubertal males, which is a function of androgen-related odors from 
the postpubertal rat eliciting aggressive attacks from the adult due to infamiliarity (124). It is this 
basis in social recognition that first allowed Dantzer, et al. to show that social memory could be 
modulated by neurohypophyseal peptides (121). This is likely the first experiment that used 
social exploration as a tool to measure the effects of neuro-active compounds. Social exploratory 
behavior was adapted from social memory testing by using a different juvenile at each 
observation time point (127), and due to the advantage of the lack of habituation when using a 
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novel juvenile, social exploration has been routinely used as a sensitive test of 
immunobehavioral perturbation. Bluthé, et al. adapted the rat-based Dantzer procedure to mice 
and since the test has remained largely unchanged (125).  
 
a.  Procedure 
 All observations should be made during the dark/active cycle of the mice. Mice should be 
housed individually at least 24 h prior to the initial measurement and be allowed to acclimatize to 
the procedure room (if procedure room differs from housing room) for the time period in which 
they are individually housed. In some studies, infrared light is used with the aid of infrared- or 
nightvision-capable cameras (125,127), but use of red-tinted lighting is also acceptable, as mice 
only have limited ability to detect light from the red portion of the visible spectra (103). All 
observations of adult-juvenile interaction are video recorded during social exploration testing for 
later analysis. Within each observation/recording session, each adult mouse to be experimentally 
observed (subject mouse) is only exposed to a juvenile (challenge mouse) once. Social 
exploration is initially measured immediately prior to any experimental treatments so as to serve 
as a baseline of social exploratory activity for each subject mouse. Social exploration is 
subsequently measured at specific times following experimental treatment, usually every 2 h for 
the first 12 h post-treatment, and then every 12 thereafter until recovery is reached (125,127). A 
test session/observation time point consists of introducing a novel challenge mouse (conspecific 
juvenile mouse of the same sex) into the home cage of the subject mouse for 5 minutes before 
returning the juvenile to its own home cage (125,127-128). In some instances, the juvenile 
challenge mouse is housed in a clean 7.62 cm x 7.62 cm x 7.62 cm wire mesh enclosure (baby 
cage) when introduced into the home cage of the subject mouse (68) to avoid undesired 
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aggressiveness seen with certain mouse strains like C57BL/6 mice. If a baby cage is used, it is 
best to acclimate subject mice to the wire mesh enclosure by including it in their home cage 
during single housing. Once the experiment is completed, the duration (in s) of exploration or 
investigation of the challenge mouse by the subject mouse is recorded from analysis of the video 
record (68,125,127). Preferably, analysis of the video record should utilize automated video 
tracking software (129) such as that developed by Noldus Information Technology (Leesburg, 
VA). In general, tracking software eliminates observer bias and provides more consistent results. 
When using tracking software, care must be given as to mouse color versus background color so 
that the animal is easily distinguished. If tracking software is not available, a trained observer 
blinded to the treatment groups (blinded trained observer) can manually quantify social 
exploration without significant prejudice (125,127). Observer training for all video review 
behavior testing is best accomplished by having personnel new to scoring a behavioral test 
evaluate previously analyzed videos that have been scored and validated (proficiency testing). 
When the scoring skills of the trainee observer are within plus/minus 10% of a novel validated 
video in three consecutive evaluations of novel validated videos, the observer trainee is deemed 
proficient. This same training should be followed when educating personnel to the use of 
automated tracking software. During manual video review the blinded trained observer uses a 
stopwatch to record the time of interaction initiated by the subject mouse with the challenge 
mouse throughout the 5 min designated investigational period. Social exploration is considered 
to be subject mouse-to-challenge mouse investigation (not the opposite), including ano-genital 
sniffing, nosing, following and grooming. With use of a baby cage, nose-to-cage contact is 
considered exploration. Social exploration is typically shown in graphical display using either 
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raw seconds of exploration at each time point (125) or as percent control or percent baseline 
(68). 
 
2. Locomotor activity 
 As lethargy is a core symptom of sickness behavior, locomotion (120) can be used as a 
technically easy and high through-put measure of sickness behavior. Spontaneous locomotor 
activity is advantageous in that it can be assessed without moving mice from their home cage, 
and automated video tracking software can be easily used for analysis. In addition, wide screen 
video capture allows for up to 8 mice to be observed at once. Alternatively, specifically designed 
activity chambers (Versamax from AccuScan Instruments, Columbus, OH) with built-in infrared 
beam detection systems can be used (130) allowing for real-time analysis. Such testing 
platforms, however, introduce an element of novel environment and need to be thoroughly 
cleaned between each mouse tested.  
 
a.  Procedure 
 All observations should be made during the dark/active cycle of the mice. Mice should be 
housed individually at least 24 h prior to the initial measurement and be allowed to acclimatize to 
the procedure room (if procedure room differs from the housing room) for the time period in 
which they are individually housed. As with social exploration, infrared or red lights can be used 
to provide illumination. At each time point of interest, mouse movement is recorded for 5 min 
(81), with a camera placed over the center of a single cage or grouping of cages. If multiple mice 
are being recorded during a given observation point, they should be shielded from one another’s 
view. Movement including total distance traveled, velocity and time spent moving is best 
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determined from the video record using automated tracking software. However, if tracking 
software is not available videos can be hand scored by a blinded trained observer. To score 
manually, a thin-line grid comprised of 6 equally sized rectangles is affixed to the television or 
monitor screen directly over the cage and the blinded trained observer counts the number of 
times the mouse crosses a line (line-crossing) throughout the 5 min designated investigational 
period. A mouse is only considered to have line-crossed if both fore-and hind limbs cross a line 
(128).  
 A more powerful method for assessing mouse locomotor activity is through long duration 
(hrs-days) tracking. This is required when detailing mouse crepuscular movement. While video 
recording can be used for such evaluation, the data collection, storage and interpretation can be 
burdensome-to-prohibitive due to video file sizes. Therefore, the use of biotelemetry is the 
preferred method for this type of testing (131). With this method, a biotelemetric emitter is 
surgically implanted within the peritoneum of a mouse and a receiver pad linked to a PC running 
data collection software is placed directly underneath the home cage of the implanted mouse 
(Mini Mitter, Bend, OR). Mouse movement is tracked and recorded automatically. Specific 
procedures and training for this method should be provided by the manufacture of the device 
chosen. 
 
3. Food consumption 
 Food consumption, (or disappearance, as discussed below), is an indicator of sickness, as 
individuals experiencing illness often exhibit anorexia. Food consumption gives an indication of 
whether anorexia is present, which could further be used to indicate if sickness behavior is 
occurring (14,122). Food consumption can be measured in at least two different ways, as 
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outlined below. The first uses “food disappearance,” which is often interpreted/estimated as food 
consumption. 
 
a.  Food disappearance procedure 
 Mice should be individually housed as per social exploration at least 24 h prior to 
experimentation. With single housing, food should be moved from the overhead cage food 
hopper and placed in a 8 cm diameter x 5 cm stainless steel bowl in the cage. Steel is preferred 
over ceramic because ceramic containers can absorb water if they are not completely glazed. In 
addition, steel dishes can be magnetically secured to the cage bottom or side with the use of a 
strong magnet. This prevents mice from tipping the bowl and spilling food which can easily 
occur with plastic bowls. After the acclimation period, and just prior to initiation of testing, new 
food should be added to the steel bowl and the bowl weighed. This process should occur at the 
very beginning of the dark/active cycle of the mice in order not to disturb mice during their sleep 
cycle. Food disappearance is measured by weighing the bowl plus food at fixed intervals, such as 
every 24 h. For longer term experiments, food can be re-added to the bowl and reweighed (122). 
The term food disappearance is used in place of food consumption because not all food is 
ingested. Some food inadvertently falls in the cage bedding (132).  
 
b. Food consumption procedure 
 Mice should be individually housed as per social exploration at least 24 h prior to 
experimentation. 24 h prior to testing mice should be fasted but allowed full access to water. An 
empty 8 cm diameter x 5 cm stainless steel food bowl should be present in the cage. 1 hr prior to 
testing, mice should be removed to similarly sized cage without bedding but with full water 
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access. Testing is initiated by wiping the bottom of the bedding-less cage clean and placing a 
pre-weighed bowl with food in the cage. After 1 hr the food bowl is removed and weighed as are 
any food remnants within the cage. The difference between food bowl food disappearance and 
food collected from the cage floor is considered food consumed (130). 
 A more powerful method for assessing food disappearance and/or consumption is 
through use of automated food and water intake measurement systems where food and/or water 
intake initiated by the animal is evaluated by computer controlled electronics (BioDAQ, New 
Brunswick, NJ). Specific procedures and training for this method should be provided by the 
manufacture of the device chosen. 
 
4. Rotarod testing 
 Inducers of neuroimmune activation and sickness behavior impair motor coordination 
and induce physical fatigue (123). The rotarod performance test can measure motor coordination 
(5157) by assessing how well mice avoid falling of a rotating rod (133). Some strains of mice 
progressively perform better on the rotarod test during repeated trials at the same rotational speed 
indicating a physical training or memory component to this procedure (134-135). Rotarod 
apparatuses are available via commercial vendors such as AccuScan Instruments (Columbus 
OH), with some variance in features (number of lanes and/or rod diameter for example). In 
general, rotarod apparatuses have the same basic design featuring a 3-9 cm diameter rod (51,134) 
partitioned by plastic divider discs spaced evenly longitudinally along the rod,. The end point 
measured is latency to fall from the rod (136). Fall detection ranges from pressure-sensitive pads 
located under the rod to infrared beams that automatically stop an integrated timer when hit or 
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blocked, respectively. Rotarod performance can, however, be assessed manually from a video 
record (136) by a blinded trained observer or by automated tracking software. 
 
a. Procedure 
 Single-housing prior to testing is not required but, like with social exploration, mice 
require at least 24 h of acclimation to the procedure room. Use of pre-experimentation 
acclimation to the rotarod is not agreed upon. Some have exposed (trained) mice to the rotating 
rod, by placing mice on the rod at a low speed (4 rpm (123) and 18 rpm (51)), while others have 
not (134). Pre-experimentation exposure to the rod has been done 1 week in advance of testing 
(51) and immediately prior to testing (123). Finally, the test itself can be performed in 1 of 2 
ways. The rotarod performance test measures the duration of time a mouse can remain on the 
rotating rod at a single or several fixed speeds (136). The accelerating rotarod performance test 
measures the maximum speed of rotation the mouse can tolerate before it falls from the rod in a 
fixed amount of time (134,136). All pre-test conditioning and testing should be made during the 
dark/active cycle of the mice (123), although testing has been performed during the light/inactive 
cycle as well (51). 
 
b. Rotarod performance test 
 Rotarods should be calibrated such they rotate at a constant speed, and should be kept 
clean and as odor free as possible between trials, as urine and feces on the rod can affect 
performance (136). Testing is initiated by placing mice on the rotating rotarod which rotates at a 
fixed speed. Mice are allowed to maintain themselves on the rod as long as they can and the test 
session continues until they fall or a designated time point is achieved such as 1-5 min on the 
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rod. At such time the latency to fall is recorded. Fixed speed trials are best used after significant 
validation testing on the strain of mouse chosen and are best used on mice with significant loss 
of coordination because small losses of coordination may not manifest at the speed or time 
chosen. Some testing protocols investigate several different speeds increasing with each trial. An 
example of increasing speeds used is 5, 8, 15, 20, 24, 31, 33 and 44 rpm (136). Mouse rest time 
between increasing speed trials ranges from 10-60 min (134,136). 
 
c. Accelerating rotarod performance test 
 Pre-conditions are similar as for non-accelerating rotarod testing. This test differs in that 
the rod accelerates at a constant rate through some specified range of speed (4 to 40 rpm) over a 
fixed amount of time (5 min). Mice remain on the rod for as long as they can and speed of the 
rod at the time of falling is the recorded end point (134). 
 For both methods of rotarod testing, motor learning can be assessed by performing daily 
repeated trials to determine if mouse time spent on the rod (fixed rod speed) or rod speed 
endured (accelerating rod speed) improves from trial to trial (134).  
 
D) DEPRESSIVE/ANXIETY-LIKE BEHAVIORS 
 Depression and anxiety are well known consequences of neuroimmune activation 
(2,130,137). However, the difficulty in assessing and distinguishing depressive/anxiety-like 
responses to conditions or experimental treatments lies in the fact that sickness behavior 
symptoms can overlap with depressive/anxiety-like behaviors. Sickness-induced reduced 
locomotion is a key confound in that most tests designed to measure depressive/anxiety-like 
behaviors require mouse movement (2). For this reason, behavioral testing for 
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depressive/anxiety-like behaviors following exogenous activation of the neuroimmune system 
should be performed only after overt physical symptoms of sickness have subsided and 
spontaneous locomotion has returned to pre-treatment levels. Importantly, the presence of 
depressive/anxiety-like behaviors should be confirmed using anti-depressive and/or anxiolytic 
therapies to improve/resolve the identified depressed or anxious behavior (2). Tests for 
depressive/anxiety-like behaviors include burrowing (81,138), the elevated plus maze (139), the 
open field test (140-141), the zero maze test (134), the tail suspension test (2), sucrose/saccharin 
preference test (2) and the forced swim (aka Porsolt) test (2). The forced swim test is the test best 
validated for depression due to its responsiveness to anti-depressives (142). However, 
investigators should refrain from using any one single test to definitively measure 
depressive/anxiety-like behaviors. Such behaviors are best examined using a battery of tests. 
Unfortunately, there is no ideal combination of tests because confounds are mouse 
strain/model/gender and experimental treatment specific. As an example, sucrose/saccharin 
preference testing should not be used in mouse testing where serum leptin is affected due to the 
impact of leptin levels on sweet taste detection by the mouse tongue (88).  
 
1. Burrowing 
 Rodents are well known burrowers (138). This behavior is related to tunnel maintenance 
and possibly defense. Defensive burying is a known indicator of anxiety and can, itself, be 
measured (138). Burrowing appears to be largely hippocampal-driven but mouse strain 
differences exist with C57BL/6 mice burrowing more than 129ES2/Sv mice (138). Burrowing is 
associated with depressive/anxiety-like behavior where reduced burrowing reflects an increased 
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depressive/anxiety-like state (81). As burrowing utilizes relatively simple equipment and 
minimal labor, it is a simple and inexpensive method for evaluating immunobehaviors (81,138). 
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Mice should be 
individually housed as per social exploration at least 24 h prior to experimentation and, with 
single housing; a clean empty burrowing tube should be placed in the cage. Burrowing tubes can 
be constructed from standard white 6.8 cm diameter PVC piping cut to 20 cm in length (138). 
The open end of the burrowing tube is elevated 3 cm by bolting two 50 mm machine screws 1 
cm from the open end, and spaced so that the tube entrance is elevated. This elevation keeps 
burrowing substrate from spilling out of the open end. The closed end is sealed with a standard 
PVC end cap (81). Testing should begin 3 h prior to the onset of the dark/active phase of the 
light cycle and is initiated with addition of burrowing substrate to the tube (81). The burrowing 
substrate used needs to be suitable to the mouse strain and experimental treatment. Pelleted 
mouse chow, gravel or sand are common materials used for burrowing (138). The burrowing 
tube can be completely filled (138) or filled with a fixed amount of substrate (81) if ceiling 
effects are not a concern. Ceiling effects arise with vigorous borrowers. These mice will remove 
all substrate from a tube in a rapid time frame obscuring any difference in burrowing activity 
relative to time. After substrate is placed in the burrow, the burrow plus substrate is weighed and 
returned to the cage. If mouse chow is used as a substrate, food from the cage food hopper 
should be removed for the duration of the burrowing test (138). Depending on anticipated mouse 
burrowing activity, experimental observation time points can range from 1-24 hrs. Amount 
burrowed (in grams) is calculated from the pre- and post-burrowing weight of the tube plus 
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substrate. Following a measurement the burrowing tube can be refilled, reweighed and returned 
to the cage for additional testing (138). Alternatively, a single measurement of burrowing can be 
utilized (81). Occasionally, with poorly burrowing mice, one or several training sessions may be 
necessary, and a practice run with the mice to be used in the experiment can, and has been shown 
to, improve burrowing activity and reduce variability between animals (138). 
 
2. Elevated plus maze 
 The elevated plus maze (EPM) is a simple method to measure anxiety-like behavior in 
mice. Anxiety is assessed by comparing the time spent in the open (exposed) versus closed 
(walled) arms of a 4-arm radial maze (139). The advantage to the elevated plus maze is that it 
eschews use of noxious stimuli like foot shock, food/water deprivation and/or loud noise. 
Instead, it relies on the predilection of mice to favor dark enclosed spaces over open and 
obviously elevated environments (139). Accommodation and/or learning can occur with repeated 
exposures to the maze. Therefore, EPM is generally administered as a single exposure with 
control mice for comparison (139).  
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. The maze can be made of a variety of materials but those that 
can be easily wiped clean between each mouse tested like stainless steel or plastic are 
recommended. Maze shape is that of a plus sign where the four arms are spaced 90° apart, 
radiating from an open central 5 cm x 5 cm platform. Arm length and width are 25 cm x 5 cm, 
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respectively. Maze elevation should be at least 40 cm from the floor (139,143). Arm wall height 
is 15 cm in the “closed” arms and there are no side walls in the “open” arms. The central 5 cm x 
5 cm platform has no walls. The open arms are at 180° from each other, likewise with the closed 
arms. Unlike the tests described above, EPM should be well lit by overhead white light. 
Significant arm wall-generated shadows, especially those confined to a single arm, should be 
avoided. Testing is initiated by placing the mouse in the open central 5 cm x 5 cm platform. Each 
subject mouse needs to be introduced to the maze in a similar fashion and placed on the maze in 
the same spot with analogous orientation (139). Mouse exploration is video recorded for 5 min 
(139) to 10 min (144). Time spent in open and closed arms, the number of entries between arms, 
(defined as all 4 paws of the mouse crossing the threshold of an arm), frequency of head-dips 
(downward movement of the mouse head toward the floor from an open arm), rears and stretch-
attend postures (139) are best determined from the video record using automated tracking 
software (128). If tracking software is not available videos can be hand scored by a blinded 
trained observer (139). 
 
3. Open field test 
 The open field test (OFT) can be used to measure movement (141) and anxiety-like 
behavior (140-141). OFT apparatuses are walled arenas that vary in shape (square, rectangle, 
circle) and size (250-2500 cm
2
) (141). OFT testing should not be used as a surrogate test for 
spontaneous locomotor activity because the OFT uses a novel environment (141). Anxiety-like 
behavior in the OFT is evaluated by examining mouse movement throughout the arena with a 
special focus on the amount of time the mouse spends/moves next to walls of the OFT apparatus 
(thigmotaxis). The novelty, size and white light illumination of the OFT contribute to 
 
 
39 
 
anxiogenesis (141). Procedures vary considerably but the open field arena is usually brightly lit 
in studies investigating anxiety (140). 
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. For testing of anxiety-like behaviors the arena should be 
larger than 1600 cm
2
 (141). Arena wall height should be at least 35 cm so as to limit the ability 
of the mouse to see over/above the arena. The arena can be made of a variety of materials but 
those that can be easily wiped clean between each mouse tested, like stainless steel or plastic, are 
recommended. Testing is initiated by placing the mouse in the center of the arena, and each 
subject mouse needs to be introduced to the arena in a similar fashion and placed in the same 
spot with analogous orientation. Movement through the arena is video recorded for 5-10 min and 
analysis of movement is best documented with automated tracking software because thigmotaxis 
is easily appreciated with this method. Path tracing is a key aid in that overall patterns of 
movement can be evaluated. Such patterns supplement the usual measurements of time spent 
adjacent to the arena walls, wall preferences, time spent not adjacent to the arena walls, overall 
distance traveled, velocity and time spent moving. Videos can be manually examined using a 
line-crossing scoring approach (similar to that described for spontaneous locomotor activity) but 
this method should be carefully validated due to the complex grid pattern needed to ascertain 
time spent close to the arena walls. Due to this intricacy, some have used the end point of total 
distance moved plus time spent in the central 25% of the arena (143). Finally, OFT has been 
used as a repeated measure to determine if therapeutics improve performance over time (145).  
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4. Zero maze 
 Like the EPM, the zero maze measures anxiety-like behaviors in mice (134) by using 
elevation and open and closed areas. Therefore, time spent in the open indicates a reduced level 
of fear/anxiety as demonstrated by use of anxiolytic agents and their ability to increase time 
spent in the open area of the zero maze (134). The advantage of the zero maze over the EPM is 
the elimination of the central platform of EPMs, which can complicate analysis of open/closed 
arm comparisons (146).  
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. Maze design varies but in general is comprised of a circular 
track 30-45 cm in diameter that is 3-5 cm wide. Maze elevation should be at least 40 cm from the 
floor (134,147). The track should be divided into four quadrants with two quadrants having no 
side walls and two quadrants having side walls at least 15 cm in height. These open and closed 
areas should alternate. As with all maze constructions, materials that are easily wiped clean 
between each mouse tested are recommended (134,146-147). Ample but dim (40-60 lux) white 
lighting should be used to achieve similar illumination of both the open and closed quadrants 
(146). Testing is initiated by introducing the subject mouse to the middle of a closed quadrant 
(designated as the starting quadrant). Each subject mouse needs to be introduced to the maze in a 
similar fashion and placed on the maze in the same place and orientation. Mouse exploration is 
video recorded for 5 min (146). Time spent in open and walled arms, the number of transitions 
between open and walled quadrants, number of rears, number of head-dips (the actual dipping of 
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the head over the edge of the track in an open quadrant), time spent grooming, the number of 
stretch attend postures and number of fecal boli in each type of quadrant is best determined by 
using a combination of automated tracking software and direct observation after testing (fecal 
boli) (134,146). If tracking software is not available videos can be hand scored by a blinded 
trained observer. Entry into a quadrant occurs when all 4 paws cross the threshold of an open or 
walled area (146). 
 
5. Tail suspension test 
 The tail suspension test (TST) is a commonly used behavioral test for assessing 
depressive-like behavior in mice. It is thought to induce an escape response (148). With 
increased depressive-like behavior the mouse fails to extricate itself from the apparatus and 
becomes immobile. Increased immobility indicates a greater degree of depressive symptoms 
(149). Importantly, antidepressants shorten immmobility offering a degree of validation to the 
test’s usefulness in measuring depressive-like behaviors (148). The TST can be automated 
through use of commercially available apparatuses that utilize computer-linked linear load cells 
and load cell filters to determine mouse movement/struggle (Med Associates, St Albans, VT). As 
with any commercially purchased device, specific procedures and training should be provided by 
the manufacture of the device chosen. However, certain basic procedures should be followed and 
considered with use of the TST including the difficulty in examining young (especially 
C57BL/6) mice due to their robust tail climbing behavior and penchant for extracting themselves 
from the device.  
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a. Procedure 
 Unlike all the previous behavioral tests described the TST should be administered during 
the light/inactive cycle of the mice. Single-housing prior to testing is not required but, like with 
social exploration, mice need at least 24 h of acclimation to the procedure room. Testing is 
initiated by affixing the mouse to the apparatus “hook” with adhesive tape wrapped around the 
tail at three quarters of its length from base. Hook the mouse to the apparatus through the tape as 
close to the tail as possible. The tail should remain straight so as not to injure the mouse. Mice 
should be suspended as uniformly as possible, and if multi-mouse devices are used the mice 
should be shielded from each other’s view (149). Immobility verse movement/struggle should be 
measured for 6 min. Non-automated devices can be constructed, which are essentially chambers 
with hooks. Mouse behavior can be video recorded and immobility determined from the video 
record by automated tracking software (150) or a blinded trained observer (151). With any of the 
aforementioned analysis techniques, time of immobility is compared between control and 
experimental groups of mice (149). 
 
6. Forced swim test 
 The forced swim test (FST), also called the Porsolt test for the investigator who 
developed the test in rodents, like the TST, is a tool for assessing depressive-like behavior in 
mice. The FST is relatively easy to administer (152) and felt to be the best validated test for 
depression by the pharmaceutical industry (153) This test evolved from the observation that rats 
will develop an immobile posture after an initial attempt to escape from an inescapable cylinder 
filled with water. FST-induced immobility is thought to represent behavioral despair (failure of 
persistent escape behavior) or a development of passive behavior that causes the animal to stop 
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actively coping with a stressor (152). The FST has several disadvantages when compared to the 
TST. The FST appears to be more stressful for mice and carries a risk of hypothermia (149). 
Mice of varying fatness are also difficult to assess due to inherent buoyancy differences. 
 
a. Procedure 
 Like the TST, the FST should be administered during the light/inactive cycle of the mice 
(153). Single-housing prior to testing is not required but, like with social exploration, mice need 
at least 24 h of acclimation to the procedure room. As with most device requiring tests, 
equipment design varies. A simple set up is to use clean white or black cylindrical PVC 
containers 16 cm in diameter and 31 cm in height (essentially 2 gallon open head pails) 
containing 20 cm of water maintained at 25°C ± 1°C (21). The FST should be performed under 
30 lux white light (154). Testing is initiated by introducing the subject mouse to the water-filled 
container. Mouse swimming is video recorded for 6 min (21). Immobility is determined from the 
video record from the last 5 min of the FST using either automated tracking software (155) or a 
blinded trained observer (21). Immobility scoring should not include movements necessary for 
the mouse to maintain its head above water (149). Like the TST, time of immobility is compared 
between control and experimental groups of mice. 
 
7. Sucrose/saccharin preference 
 Anhedonia, or the inability to gain pleasure from otherwise enjoyable experiences, is one 
of the features of depression (156-157). In mice, their preference for sweetened solutions has 
been exploited to measure anhedonia. The decreased consumption of a sweet-tasting solution is 
indicative of anhedonic behavior and can be reversed with anti-depressives (157). Sucrose (157) 
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and saccharin (81) solutions are commonly used opposite normal tap water in a 2-choice test. For 
investigators concerned with mouse caloric intake, saccharin is the recommended sweetener 
(81). Advantages to the sucrose/saccharin preference test is that it can be run continuously for 
many days without significant concern of adaptation or learning. 
 
a. Procedure 
 Three days prior to testing mice should be singly housed in standard cages adapted for 2-
bottle water access (adaptation phase). If the experimental design requires mice to be challenged 
with a neuroimmune activator, each bottle should contain either saccharin as a 0.4% sodium 
saccharin solution (1% for sucrose can substituted for saccharin) or water. If the experimental 
design does not require exogenous challenge as with a comparison of mice of different strains or 
genders, the adaptation phase should consist of both bottles being filled with water. The adaption 
phase is especially important to experiments using endogenous immune activators so as not to 
elicit the behavior of conditioned aversion where the mouse associates a newly introduced 
substance like saccharin/sucrose with the cause of their loss of well being (158). After the 
adaptation phase, mice are usually administered a challenge at the beginning of their dark/active 
cycle and then returned to the cage in which they were adapted in the presence of both water and 
saccharin (testing phase). Fluid consumption is recorded every 24 hours. Fluid consumption is 
determined by bottle weight (81). In order to control for the development of bottle bias, bottle 
position of water versus sweetened solution should be switched on a regular but defined basis 
such as halfway through the experiment or every 24 h. Bottle switching should also be practiced 
during the adaptation phase usually at 24 h intervals. Sweetened solution preference is generally 
reported as a percentage of sweetened solution consumption/disappearance to total fluid 
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consumption/disappearance (157). A 50/50 consumption of sweetened solution to water equates 
to anhedonia but a ratio in which water consumption/disappearance exceeds sweetened solution 
consumption/disappearance is indicative of aversion and should trigger concerns as to the 
applicability of the results to the measurement of depressive-like behaviors (81). 
 
E) COGNITIVE BEHAVIORS 
 Neuroimmune activation can dramatically impact cognitive function (79) causing 
learning and memory deficits. Most mouse-based behavioral tests for cognitive function make 
use of memory and focus either on the ability of the mouse to form new memories (memory 
formation) or recall old memories (memory retention). Memories involving location (spatial 
memory) are especially utilized (79). A cornucopia of cognitive function tests exist. Some of 
these tests have been specifically designed to identify specialized aspects of learning and 
memory such as olfactory memory (159). Given that peripheral innate immune driven 
neuroimmune activation is relatively brain-region non-specific, cognitive tests that cover more 
global aspects of brain function are favored by PNI investigators.  
 
1. Novel object recognition 
 Novel object recognition is a test of working memory in mice. The test exploits the innate 
tendency of mice to investigate a new entity (160). Novel object testing is one of the simplest of 
cognition tests, but test variations are described that add significant complexity through mixing 
of objects, object placement (novel location testing) and testing arena conditions (81,160-162). 
The setup for novel object recognition typically depends on what sort of memory function a 
researcher desires to investigate (160). An advantage of novel object testing over other 
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seemingly more powerful maze-based memory tests is its adaptability to repeated measure 
testing (160). In essence, as long as the mouse is well adapted to the familiar object, changing 
out the novel object after each exposure allows for a new round of testing. This feature is very 
useful when looking at recovery from a neuroimmune challenge.  
 
a. Memory recall procedure 
 All observations should be made during the dark/active cycle of the mice. Mice should be 
housed individually at least 24 h prior to the initial measurement. The 24 h training phase is 
initiated by introducing two identical objects into the home cage (standard shoe-box cage size; 
28 cm in length; 17 cm in width; 12.5 cm in height) of the singly-housed mouse. The objects are 
placed 10 cm apart at the short-side wall end, 5 cm from the short side wall and 3.5 cm from the 
long-side wall. Tall (3-5 cm in height) complex objects are preferred because when a tall 
complex object is introduced during the testing phase it provokes significantly more exploration 
time. Tall complex objects can be constructed from Lego® blocks (Enfield, CT). Magnets can be 
used to secure the structures to the cage floor. All structures should be taken apart and cleaned 
prior to reuse. After the 24 h training phase, the mouse is subjected to the chosen neuroimmune 
activator. At relevant times after the applied immunobehavioral challenge, the memory recall 
testing phase is initiated by placing the mouse in a home-cage like arena (including bedding) 
which contains a similar object set up as in the training phase where one of the familiar objects 
has been replaced by a novel tall complex object. The mouse should be introduced at the cage 
end opposite the objects. No spatial clues should be present in the testing/training area. Object 
exploratory behavior is video recorded for 5 min and object investigation is determined from the 
video record by either automated tracking software or by a blinded trained observer. Object 
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exploration is considered as contact by mouth, nose or paw. Accidental contact such as bumping 
into an object while passing should not be considered (161). Mice with a memory recall deficit 
should examine both the familiar and novel objects equally (163). Once recovered from 
neuroimmune activation, mice should explore the novel object over the familiar object. This test 
cannot be performed as a repeated measure and, thus, requires separate groups of mice to 
determine at what time after neuroimmune activation cognitive recovery occurs. 
 
b. Memory formation procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. Memory formation testing differs from recall testing in that 
training occurs after endogenous activation of the neuroimmune system instead of before (160). 
The procedure is identical to the above except at relevant times after the applied 
immunobehavioral challenge mice are trained for 1 hr with the two familiar objects in the 
shoebox-sized testing arena then returned to the home cage. After 1 hr in the home cage, testing 
is initiated by placing the mouse back in the testing arena where one of the familiar objects has 
been replaced by a novel object. Recording time and scoring are identical to the above. Mice 
with a formation deficit should examine both the familiar and novel objects equally. Once 
recovered from neuroimmune activation, mice should explore the novel object over the familiar 
object. This test can be performed as a repeated measure as long as the novel object is always 
new. 
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2. Fear conditioned learning 
 Fear conditioned learning is a form of classical (Pavlovian) conditioning where an 
association between a stimuli and its aversive consequence(s) is made (164). Fear conditioning is 
a highly conserved behavior that occurs in mice both in the laboratory and in the wild. In PNI 
research, it is a useful tool for evaluating emotional memory formation and recall (164). Fear 
conditioned learning is generally a one-trial learning procedure and is unique from other 
cognitive tests in that the investigator regulates the parameters of the stimulus. Factors that 
impact mouse hearing, like age, are important to consider prior to use of fear conditioned 
learning, as auditory sensory decline will negatively affect sound-based contextual cues (164). 
Like novel object testing, fear conditioned learning can be used to test memory formation and 
memory recall. For memory formation testing, the training phase (see below) is conducted after 
neuroimmune stimulation. For memory recall testing, the training phase is conducted prior to 
neuroimmune stimulation. 
 
a. Cued fear conditioning procedure 
 All observations should be made during the dark/active cycle of the mice. Mice should be 
single housed for this behavioral procedure and, like with social exploration, mice need at least 
24 h of acclimation to the procedure room. Automated commercially-available fear conditioning 
apparatuses (San Diego Instruments, San Diego, CA) are the easiest way to adapt this testing 
paradigm. General apparatus parameters are fairly uniform. There is a shock generator and 
scrambler that delivers a 0.1-1.0 mA foot shock through a wire grid floor in concert with a sound 
generator that produces auditory cues, all contained in a shoebox cage-sized chamber (164). It is 
recommended that sound meters and voltmeters are used to verify and record stimulus intensities 
 
 
49 
 
(164). Prior to testing mice require training. In the initial training session, mice are placed in the 
fear conditioning apparatus for 120 sec (phase A) before the presentation of a 30 sec sound cue 
(phase B). A 2 sec foot shock is delivered immediately after the sound cue (phase C). Mice are 
returned to their home cages 30 sec after the shock ends. Repeat training can be utilized to 
reinforce the memory. As noted above, training relative to neuroimmune stimulation determines 
whether memory formation or recall is being tested. Testing is usually initiated 24 h post-training 
and consists of re-introducing the mouse to the fear conditioning apparatus and re-presenting the 
sound cue. The sound cue now lasts for 180 sec. Mouse behavior during this 180 sec period is 
recorded with a side-mounted video camera. However, apparatuses with a beam detection grid 
system linked to a PC can automate analysis. With video recording, freezing and non-freezing 
behavior is scored by a blinded trained observer at 10 sec intervals. Freezing is considered a 
complete lack of mouse movement (164). Fear conditioning is presented as number of freezing 
episodes. With an automated detection system, actual time spent frozen can be determined. 
 
b. Contextual fear conditioned procedure 
 Contextual fear conditioning uses the same pre-experimental and scoring procedures as 
for cued fear conditioning. However, in contextual fear conditioning, no sound cues are 
delivered. The mouse is expected to associate the apparatus with the foot shock. Testing time is 
180 sec. Complexity can be added by using an alterable microenvironment within the fear 
conditioning apparatus (altered contextual fear conditioning). A variety of cues from visual to 
olfactory can then be utilized (164).  
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3. Spontaneous alternation 
 Spontaneous alternation is the simplest spatial memory test to perform in mice. Increases 
and decreases in spontaneous or perfect alternations reflect improvements and impairments, 
respectively, in spatial memory function (81,165). Spontaneous alternation can be performed in a 
variety of maze types including radial arm, T and Y (81,166). Sub-forms of spontaneous 
alternation testing have also been described including forced-trial alternation, where one arm of 
the maze is closed off, forcing the mouse to enter the open arm without choice. In a subsequent 
testing, the closed arm is then made available (166). Interestingly, certain mouse strains have 
been shown to be biased in their turning direction (166), and this should be considered and 
controlled for. Like novel object testing, spontaneous alternation can be used to test memory 
formation and memory recall. For memory formation testing, spontaneous alternation test is 
conducted after neuroimmune stimulation. For memory recall testing, the mouse is tested in the 
Y-maze (which serves as a training period), exposed to a neuroimmune activator and then re-
tested in the Y-maze. In addition, spontaneous alternation can be performed as a repeated 
measure and maze performance usually increases with repetition. Repeated measure testing is 
generally preferred because a “one and done” testing strategy is more indicative of locomotor 
activity and less dependent on spatial memory (166).   
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. As with all mazes described previously, the Y-maze used for 
spontaneous alternation should be made of a material that can be easily wiped clean between 
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each mouse tested. Clear Plexiglas is preferred so that a different black-colored design (lines, 
circles or triangles) can be affixed to the outside wall of each arm to provide intra-maze visual 
cues. The maze base is a opaque blue. Maze shape is 3 equally spaced arms 120° from each other 
(radial Y). Arm length is 40 cm, arm width is 9 cm and arm wall height is 16 cm (81). Testing is 
initiated by placing the mouse into the distal end of a randomly chosen arm (as assigned by a 
random number generator). Each subject mouse needs to be introduced to the maze in a similar 
fashion and placed on the maze with analogous orientation. Mouse exploration is recorded for 5 
min (3 and 15 min have also been used (167)). If the experimental design allows, mice should be 
tested every 24 h for 4 consecutive days. Perfect alternations are determined from the video 
record by a blinded trained observer. A perfect alternation is defined as exploration of two 
different arms of the maze sequentially before a return to the starting arm (e.g. beginning in arm 
“C,” moving to arm “A,” then to arm “B,” before returning to arm “C” again) (81). Number of 
“regular” alternations should also be scored. Regular alternations are defined as entering all three 
arms within a sequence of four arm entries (e.g. ACAB is considered an alternation, whereas 
ACAC is not) (166). Arm entries occur when all four paws of the mouse pass the threshold of the 
arm entrance (81). Results are represented as total alternations or perfect alternations divided into 
the total possible alternations or perfect alternations, respectively (166). Perfect alternation 
scoring is considered more rigorous. 
 
4. Barnes maze 
 The Barnes maze, like spontaneous alternation, is a test of spatial memory. This test 
combines several aspects of the previously mentioned mazes including elevation, open/exposed 
illuminated space and a dark enclosed area (168). Use of the Barnes maze was popularized as an 
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alternative to the Morris water maze (described in the next section) because swimming may 
produce anxiety (169). Removal of water also allows for more balanced testing of mice of 
different fat density due to elimination of the buoyancy effect. Importantly, the Barnes maze 
appears to rely on the same hippocampal-dependent memory function as the Morris water maze 
(168). As with any maze designed to test spatial memory, extra- and intra-maze cues serve as 
location reference points and without these cues mice perform less well (168). Like spontaneous 
alternation, the Barnes maze can be used to test memory formation and recall depending on when 
neuroimmune activation is triggered relative to the training period. However, recall is 
significantly simpler to measure when using transient memory impairment paradigms.  
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. As with all mazes, construction materials should be easily 
cleanable. A typical Barnes maze is a 90 cm diameter white acrylic disc with 12 equally spaced 
through-and-through holes arranged 5 cm from the outer edge of the disc. Hole diameter is 5 cm 
and the maze is situated 56 cm off the floor (168). A tunnel like extension attached to an 
enclosed sealable 8 x 8 x 8 cm chamber (escape chamber) needs to be freely fittable to one of the 
holes from underneath the maze. Thus, for the mouse to escape the maze, it must enter a hole. 
Extra maze cues, such as different geometric shapes are placed around the maze and on the walls 
of the room (169). Prior to testing multi-day training is required. Training occurs 4 times per day 
(during the dark/active cycle of the mouse) for a 5-day period. In each session, the mouse is 
introduced to the maze (lit at 1200 lux) via a non transparent holding chamber placed in the 
 
 
53 
 
center of the maze. Time spent in the holding chamber is 30 s. After the holding chamber is 
unsealed, the mouse is allowed to explore the maze freely for 5 min. During each training 
session, the escape chamber should remain under the same assigned escape hole with all other 
holes blocked. During the 5 min exploration period, the mouse should find the escape chamber 
hole. If the mouse fails to find the escape chamber hole, it is picked up and placed near the 
entrance of the escape chamber hole and allowed to enter. Once the mouse enters the escape 
chamber the mouse is removed from the maze and the training session is ended (168). One hr 
after the final training session a probe trial is conducted in which all of the holes are blocked 
(preventing any escape) and the mouse is allowed to explore the maze for 5 min. Successfully 
trained mice with functional spatial memory should actively search for the remembered escape 
chamber hole in the appropriate location. Mouse introduction to the maze during the probe trail 
uses the holding chamber technique as performed during training. After immunobehavioral 
stimulation, testing is initiated re-performing a single 5 min training procedure. Mouse behavior 
is video recorded and maze performance evaluated from the video record using a combination of 
automated tracking software and observation. The mouse should use the extra-maze visual cues 
to locate the remembered escape chamber (168). Scoring the trials consists of tallying the 
frequency of errors  committed before entering the escape chamber (examination of the an 
incorrect hole), timing the latency to find/enter the escape chamber and determining the path 
length to the escape chamber. Different variations of the Barnes maze exist and include a hidden-
target fixed-location modification in which the extra-maze cues were always in the same 
location, but the maze was rotated (168). 
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5.  Morris water maze 
 The Morris water maze (MWM) is used for assessing spatial or place learning. 
Advantages of the MWM include no requirement for pre-training, high reliability across 
different tank designs and proved validity in measuring hippocampal-dependent spatial and 
reference memory. Learning impairments in the MWM are independent of locomotor deficits, as 
locomotor reductions do not seem to affect swim speed (170). The MWM is an open circular 
pool filled with water. Mice must swim and search for a small, hidden platform just below the 
surface of the water in a fixed location utilizing extra-maze cues. The maze is constructed of a 
circular, stainless steel tank 122 cm in diameter, with 51 cm high walls, with non-reflective inner 
surfaces. Contrasting colors between the inside of the tank and the mouse allow easy integration 
of automated tracking software for the analysis of swim path, duration and location. As the 
purpose of the MWM test is to induce the mouse to use distal cues, any seams or recognizable 
patterns on the inside of the pool are not recommended. The platform (made of a plastic or PVC 
conduit shaft with a plastic or acrylic platform on top) is typically square or circular in shape and 
is clear or matching in color to the inside of the swim tank. The platform is positioned just below 
the water level (0.5-1 cm). Water temperature should range between 24-26 °C (171). The room 
in which the MWM test takes place in should allow for ample distal visual cues like for the 
Barnes maze. Studies have shown that lack of cues can negatively affect MWM performance 
(170). The investigator should be aware that their presence in the procedure room during MWM 
testing may make them a distal visual cue. All variations of the MWM procedure should take 
place in an illuminated, albeit indirectly lit room (to avoid reflections or glare on the water 
surface, which can make scoring with automated tracking software difficult) (170). The maze is 
divided into four, equally-sized quadrants with the platform positioned in the center of one of 
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these quadrants (170). The procedures for spatial acquisition and reversal learning are described 
below but a variety of modifications exist. A key concern in MWM spatial memory testing is 
that the probe trial should be spaced temporally from the last training session to effectively and 
reliably measure reference memory formation (170). 
 
a. Spatial acquisition procedure 
 All testing should take place during the dark/active cycle of the mice. Single-housing 
prior to testing is not required but, like with social exploration, mice need at least 24 h of 
acclimation to the procedure room. The mouse is placed (not dropped) at the selected start 
position in the maze, facing the tank wall. A timer or video tracking should be started 
immediately at the placement of the mouse in the maze. The timer remains on until the mouse 
reaches (comes in contact with) the platform. Standard trial limits of 1-2 min per trial are usually 
used, and mice that have not reached the platform should be placed on or guided to it by the 
investigator (170). The animal should remain on the platform for 15 sec. This step helps mice 
orient their position in space relative to the extra-maze cues (170). Following the inter-trial 
interval, the mouse is again placed in the maze, this time in a different but predetermined 
location (most protocols start the mice from one of four positions – south (the investigators 
position), north (opposite the investigators position), east (to the right of the investigators 
position) and west (to the left of the investigators position)). Trials are repeated 4 times per day 
for 5 days. Following training, the experimental treatment is administered and time is allowed for 
the treatment to take effect, or in the case of neuroimmune activators, for sickness behavior to 
resolve so as not to confound the results (2). The probe trial is run, during which the platform is 
removed from the maze. The probe trial is video recorded and lasts 60 s, after which the mouse is 
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removed. The objective of the probe trial is to determine whether or not the mouse can recall 
memories of where the platform was during training sessions based on the distal visual cues 
(170). End points measured in spatial acquisition include the number of platform site crossovers, 
time and distance swam in the target quadrant relative to the other quadrants, time in a 
predefined radius around the original platform position (larger than the original platform itself), 
average distance swam to target site and latency to first target site crossover. For investigators 
without automated tracking capabilities, blinded trained observers should use a timer to calculate 
the time spent in the aforementioned areas, as distance traveled is not feasible to measure with 
trained observers. Percent time spent in the target quadrant or percent of distance swam in the 
target quadrant are the most common reported end points in MWM spatial acquisition testing 
(170). 
 
b. Spatial reversal testing procedure 
 Spatial reversal testing determines the ability of the mouse to extinguish a particular 
memory in favor of forming a new one (170). In this paradigm, training procedures are the same 
as they were for spatial acquisition, but the probe trial differs. During the reversal training probe 
trial, the platform is moved, typically to the opposite side of the maze, but cues remain in their 
same position as during training trials (171). Mice are placed first on the platform for 30 s to 
allow them to gain some spatial cues as to where the new platform location is. Mice are then 
given 1-3 trials to reach the platform, starting from different locations if necessary (171). The 
same end points are used in spatial reversal training as with spatial acquisition (170). Since the 
platform remains in the maze, latency to reach the platform, swim speed and total distance swam 
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are also used as end points (171).Some variations of the MWM include repeated learning, latent 
learning and cued learning (170). 
 
F) PHYSICAL ACTIVITIES 
 An acute reduction in physical activity is a sign/symptom of sickness and is associated 
with fatigue (2). Chronic low-grade inflammation is also linked to altered patterns of physical 
exertion and fatigue (2). Physical activity and fatigability can be measured with techniques 
adopted from exercise research and include voluntary running wheel and exhaustive/forced 
running. These tests are more powerful than spontaneous and long duration locomotion testing 
described earlier in that they can tease out more subtle activity differences. Animals that engage 
in more spontaneous physical activity generally have less fatigue, higher fitness levels and better 
performance in forced exercise testing (172). Important behavioral differences appear to exist 
with spontaneous and forced exercise. Wheel running is spontaneous and thought to be under 
central nervous system control. The concept of motivation is critical to this behavior and 
sickness-associated fatigue appears to be a modulating factor (173-174). In contrast, exhaustive 
exercise, such as forced treadmill running, is generally controlled by muscle and/or 
cardiovascular limitations (175). The rapidity with which an animal discontinues an exhaustive 
exercise test may also be governed by immunobehavioral fatigue (175). PNI investigators most 
often use spontaneous wheel running (SWR) (95) and forced treadmill running (FTR) (173) to 
probe the impact of immunobehaviors on physical activity. SWR is preferred for the high 
through-put testing in that it can be remotely monitored with little demand on personnel. FTR is 
much more labor intensive but allows for considerable customization including alterability of 
duration, frequency and intensity. FTR is also considerably more stressful to mice. 
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1. Spontaneous wheel running 
 A key advantage of SWR is that it can be assessed without moving mice from their home 
cage and the length of examination time can be very long. A disadvantage is that mice need to be 
singly housed. Specialized caging is needed to accommodate the running wheel and bedding 
must be correctly adjusted and monitored so as not to interfere with the wheel. A basic running 
wheel may measure only revolutions of the wheel and may need manual resetting at each data 
collection point. Advanced running wheel systems (Mini Mitter, Bend, OR) can obtain hourly, 
daily or weekly distances run. Regardless of the running wheel sophistication, wheels need to be 
clean and well lubricated. Running wheel size and structure should also accommodate the size of 
mouse used. In long duration studies, cage cleaning and contact with animal facility and/or 
investigative personnel can result in an acute reductions in running.  For the below procedure, an 
automated, multi-channel running wheel system (Mini Mitter, Bend, OR) is utilized. Specific 
procedures and training for any given wheel should be provided by the manufacture of the device 
chosen. 
 
a. Procedure 
 Mice need to be individually housed for experiments with running wheels and need to 
acclimate to the procedure room for at least 24 h prior to experimentation. Groups of mice in 
cages with locked running wheels and in cages with no wheel present should be included for 
proper experimental controls. Prior to experimentation (such as neuroimmune activation), a 
baseline measurement is recorded in case post-hoc normalization of distance run is required. 
After immunobehavioral stimulation, mice are immediately returned to their cage and allowed 
access to the wheel (rotating, locked) or cage environment (no wheel). A 10 day course of wheel 
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running is recommended. With automated running wheel systems, total distance run is reported. 
With manual wheels, wheel revolutions are recorded and distance traveled calculated by 
multiplying the wheel circumference by the number of revolutions. A limitation in SWR is the 
absence of a running intensity marker. However, some sophisticated wheel systems can record 
revolutions/min providing some insight into intensity.  
 
2. Forced treadmill running 
 FTR better measures mouse fatigue (175). Like running wheel systems, mouse treadmills 
vary in sophistication with some allowing both uphill and downhill running (IITC Inc. Life 
Science, Woodland Hills, CA). Treadmills coupled to oxygen consumption systems can be used 
to determine mouse “fitness”. Non-rodent treadmills (Jog-A-Dog, Ottawa Lake, MI) divided into 
lanes with Plexiglas dividers allow for high through-put studies of up to 20 mice. Treadmills 
should contain a protective end (foam) to prevent mice from being thrown from the device and to 
provide an impetus to move forward should the mouse reduce its speed or stop running. Mice 
will respond to the contact of the tail/hind portion with the protective end. A ventilated cover is 
also recommended. Intra-experimental prodding can be used if a mouse or mice appear to 
predominantly “ride” the treadmill but this encouragement can lead to bias due to the difficulty 
of applying prodding evenly to every subject mouse. 
 
a. Procedure 
 All observations should be made during the dark/active cycle of the mice. Mice do not 
need to be single-housed prior to this procedure but should be allowed to acclimate for at least 24 
h to the procedure room. Prior to experimentation, mice should be trained daily for 3 days at 
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speeds of 14-20 m/min (speed depends on mouse age and strain). Mice that cannot learn the 
treadmill task should not be included in experimental studies. Training sessions should last until 
mouse exhaustion (1-2 hrs). Immunobehavioral stimulation is delivered 24 h after the final 
training session. Testing is initiated by conducting a treadmill run to exhaustion. Exhaustion is 
considered as a cease in running that is not motivated by protective end contact. Time to 
exhaustion is the measured end point. Distance to exhaustion can be calculated from the time run 
and velocity of the treadmill.  
 
G) CONCLUSION 
 Behavioral testing is a fundamental element of PNI research and mice provide a powerful 
tool for exploring the origins and relevance of sickness symptoms. Like with any experimental 
procedure, uniform agreement on exact technique between scientists has not been achieved. 
Therefore, the above should be considered an overview of how to measure sickness, 
depressive/anxietal, cognitive and physical activity behaviors. As important as appropriate 
procedures are to successful behavioral testing, pre-experiment considerations are likely the 
greatest determinate to relevance and reproducibility. It is essential that mice be housed in 
environments devoid of negative stressors and be well-adapted to any change. Variation in the 
equipment and experimental design is usually irrelevant when compared to unexpected and 
unpredictable housing conditions. In fact, wet cages, noise and unfamiliar odors are often used as 
elicitors of adverse biobehaviors. Thus, consistency, concern and care in handling mice affords 
the best foundation for success. Finally, keen observation is an additional reward, and making 
sure to note unanticipated or unusual behaviors during testing may lead to innovative discoveries 
toward the creation of new behavioral tests and immunobehavioral paradigms. 
 
 
61 
 
VII SUMMARY 
 
 There is plenty of evidence in the literature supporting the role of IR and hypoxia in the 
initiation of proinflammation. However, several questions still remain. Most of the IR studies 
performed to date have focused on end points weeks to months after exposure. Additionally, with 
the exception of the one or two studies that used very low dose IR, most of the doses tested are in 
the 10+ Gy range. The same is true for hypoxia. Many of the investigations to date have relied on 
severe hypoxic episodes where oxygen levels were decreased by at least 50% from normoxia. 
What remains unknown is how do these treatments affect neuroimmunity and/or overall 
physiology? Might they both be beneficial to the host? There are a small number of reports 
suggesting that low grade hypoxia or radiation can have beneficial effects. An example with 
hypoxia showed that moderate normobaric hypoxia (equivilent to 3000 m, or approximately 74% 
of sea level oxygen) can lead to the beneficial effect of improved running economy (RE; 
indicated by the oxygen cost while running at submaximal speeds) (176-177). Evidence for 
beneficial effects of IR come from Trott’s review on very low dose IR exposure. IR also has 
shown beneficial effect for non-malignant conditions such as psoriasis and eczema with fewer 
short and long term side effects compared to currently used effective treatments (178). Taken 
together, these findings indicate two things: 1) that treatment with low grade hypoxia or low dose 
IR results in a physiological effect, and 2) that treatments at very low doses may actually have 
beneficial health effects.  
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CHAPTER TWO
b
 
THE BIOBEHAVIORAL AND NEUROIMMUNE IMPACT OF LOW-DOSE IONIZING 
RADIATION 
 
I ABSTRACT 
 
 In the clinical setting, repeated exposures (10-30) to low-doses of ionizing radiation (≤ 
200 cGy), as seen in radiotherapy for cancer, causes fatigue. Almost nothing is known, however, 
about the fatigue inducing effects of a single exposure to environmental low-dose ionizing 
radiation that might occur during high-altitude commercial air flight, a nuclear reactor accident 
or a solar particle event (SPE). To investigate the short-term impact of low-dose ionizing 
radiation on mouse biobehaviors and neuroimmunity, male CD-1 mice were whole body 
irradiated with 50 cGy or 200 cGy of gamma or proton radiation. Gamma radiation was found to 
reduce spontaneous locomotor activity by 35% and 36%, respectively, 6 h post irradiation. In 
contrast, the motivated behavior of social exploration was un-impacted by gamma radiation. 
Examination of pro-inflammatory cytokine gene transcripts in the brain demonstrated that 
gamma radiation increased hippocampal TNF- expression as early as 4 h post-irradiation. This 
was coupled to subsequent increases in IL-1RA (8 h and 12 h post irradiation) in the cortex and 
hippocampus and reductions in activity-regulated cytoskeleton-associated protein (Arc) (24 h 
post irradiation) in the cortex. Finally, restraint stress was a significant modulator of the 
neuroimmune response to radiation blocking the ability of 200 cGy gamma radiation from 
impairing locomotor activity and altering the brain-based inflammatory response to irradiation. 
                                                          
b
 This chapter’s work has been previously published: 
York J.M., Blevins N.A., Meling D.D., Peterlin M.B., Gridley D.S., Cengel K.A., Freund G.G., 2012. The 
biobehavioral and neuroimmune impact of low-dose ionizing radiation. Brain Behav Immun 26, 218-227. 
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Taken together, these findings indicate that low-dose ionizing radiation rapidly activates the 
neuroimmune system potentially causing early onset fatigue-like symptoms in mice.  
 
II INTRODUCTION 
 
The impact of ionizing radiation on behavior and neuroimmunity is an emerging field. 
Currently, the primary focus is on clinically delivered radiation therapy to oncology patients and 
the consequent adverse biobehavioral impact these critical treatments engender (1-3). 
Therapeutic radiation involves delivery of relatively high doses (30-80 Gy/14-60 days) 
administered focally and strategically to limit treatment of uninvolved normal tissues (4). The 
majority of patients receiving radiotherapy over the past century have been treated with 
electrons, x-rays (high energy photons) or gamma-rays (high energy photons). The distinction 
between x- and gamma-rays from a radiotherapy perspective relates to the source of the photons: 
x-rays originate from outer electrons and gamma rays originate from atomic nuclei. In 
radiotherapy applications, however, both x- and gamma-rays are photons in the 1-20 MeV 
energy range. The physical properties of these forms of radiation cause maximal energy 
deposition (dose) to occur early in the tissue particle track at depths of 0.5-4 cm. Recently, there 
has been renewed interest in treating patients with heavier charged particles such as protons, 
which deposit the majority of their dose toward the end of the tissue particle track at depths up to 
20-30 cm. This affords more focused delivery of dose to deeply seated neoplasms with less 
radiation being administered to tissues more distal to the target (5). In addition to the differences 
in macroscopic dose distribution, photons and protons create disparate microscopic dose 
distributions due to dissimilar linear energy transfer (LET) coefficients. Importantly, differences 
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in microdosimetric track structure may cause photons and protons to have qualitatively and 
quantitatively unequal dose-toxicity profiles (6).   
In contrast, environmental radiation exposure is ubiquitous, of very low-dose 
(approximately 6.2 mGy/year) (7), whole body and comprised of a mix of particle types that 
include photons, electrons, protons and heavy ions. This environmental dosage, however, can 
jump significantly at altitudes that commercial aircraft fly (approximately 6.30-6.79 μGy/h (32)), 
in manned space exploration (approximately 50-100 μGy/day during interplanetary travel and 
25-50 μGy/day on planetary surfaces (8)) or during a severe nuclear reactor accident such as 
occurred at Fukishima Daiichi Nuclear Power Plant in Japan 2011 (ground air as high as 1 Gy) 
(9-10). Environmental radiation can be markedly compounded during a solar particle event 
(SPE) with doses reaching 1.4 Gy/h for skin, 0.8 Gy/h for eyes and 8 cGy for bone marrow in 
data modeling studies from the August 1972 SPE (11). In addition, SPE irradiation is primarily 
comprised of relatively superficially penetrating protons with energies less than 50 MeV. The 
energy spectra a specific SPE, however, is highly variable and some SPES have had a greater 
proportion of deeply penetrating, higher energy protons. With the anticipation of expanded near 
space/space tourism/travel, nuclear power plant construction and threat of nuclear terrorism, the 
population at risk for total body radiation exposures in the range of 0.5-2 Gy are likely to 
increase appreciably.  
 Total body exposure to ionizing radiation can lead to acute radiation syndrome (ARS) 
that includes the initial prodromal stage defined by nausea, vomiting and diarrhea (N-V-D stage) 
(19). An underappreciated component of the prodromal stage is neuroimmune system-mediated 
sickness symptoms often described as feelings of unease and weakness with an associated lack of 
motivation and energy (2,12-13). Like other maladies associated with weariness and malaise, 
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radiation-induced fatigue is a complex interplay of mental, emotional and physical biobehaviors 
that are often ignored due to concerns over the manifest illness stage and, ultimately, survival. 
The first radiation-induced behavioral effects involving the dose and type(s) of radiation present 
in SPEs were delineated in animals (predominantly primates) during the 1970s and 80s. Memory 
and cognition testing in monkeys irradiated at dose rates of 0.3, 0.8 and 1.8 Gy/min, (total dose 
of 10.0 Gy) showed that hampered performance occurred in 81% of animals at 1.8 Gy/min but 
only in 7% of animals at 0.3 Gy/min. Thus, the effective dose for radiation-induced performance 
deficits was estimated to occur at doses of 3 Gy or less (14). In addition, behavioral test 
complexity appeared impacted by ionizing radiation with tasks requiring greater physical 
exertion being affected more (14). As for rodents, conditioned taste aversion could be induced at 
doses as low as 0.25 Gy (14). Interestingly, 3 Gy of proton radiation caused a decrease in latency 
to fall in rotarod testing and loss of acoustic startle habituation (15). In sum, almost all studies 
reporting on the behavioral impact of low-dose radiation (≤10 Gy) examined endpoints of days 
to weeks post radiation. Therefore, almost nothing is known about the immunobehavioral impact 
of low-dose ionizing radiation within hours after exposure. 
 
III METHODS 
 
Materials. All reagents and chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO) except as noted. RNAlater (AM7021) and RiboPure Blood Kits (AM1928) were purchased 
from Ambion (Austin, TX). QIAGEN RNeasy Lipid Tissue Mini Kits (Cat No. 74804) were 
purchased from QIAGEN (Valencia, CA). Reverse transcription kits and primers for qPCR were 
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purchased from Applied Biosystems (Foster City, CA). Plastic containment cubes (AMAC530C) 
were purchased from AMAC Plastic Products (Petaluma, CA).  
Animals. Animal use was conducted in accordance with the Guide for the Care and Use 
of Laboratory Animals (National Research Council). Male 6-wk old CD-1 mice (n=632) were 
obtained from Taconic (Hudson, NY). Mice were group housed (4 x cage) in standard shoebox 
cages (length 28 cm; width 17 cm; height 12.5 cm) and allowed water and standard rodent chow 
ad libitum. Mice were maintained in an environmentally controlled room on a 12 h dark/light 
cycle (1900 h-0700 h) at a temperature of 72º F (22 º C) and a humidity of 45-55%. Mice tested 
were 7-8 wks of age. Video recording of animal behavior was performed under red light using a 
Sony HDR-XR500V Night Shot capable video camera (San Diego CA, USA).  
Radiation exposure. Mice were singly housed for 12 h prior to irradiation or sham 
irradiation. 
137
Cs irradiated mice were exposed to gamma radiation for no more than 10 min at a 
dose rate of 44.50 ± 0.1 cGy/min (high dose rate) to doses of 50 cGy or 200 cGy. 
137
Cs radiation 
was delivered using a Nordion GammaCell 40-Series 1 Irradiator (Ottawa, Canada). 
60
Co 
irradiated mice were exposed to gamma radiation at a dose rate of 0.5 ± 0.01 cGy/min (low-dose 
rate). 
60Co radiation was delivered using an Atomic Energy of Canada Eldorado Model ‘G’ 
irradiator (Ottawa, Canada). Proton irradiated mice were exposed to proton radiation at a dose 
rate of either 50.0 ± 0.1 cGy/min (high-dose rate) or 0.5 ± 0.01 cGy/min (low dose rate). Proton 
radiation was delivered using the horizontal clinical beam line at the Loma Linda University 
Medical Center (LLUMC, Loma Linda CA). Protons were tailored to have a similar macroscopic 
dose distribution as 
60
Co produced photons, which are considered to be the standard by which 
other forms of therapeutic radiation are compared (6,16). Sham irradiated mice were treated 
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identically to irradiated mice except the radiation source remained shielded. Irradiation occurred 
3 h prior to the start of the dark cycle (1600 h).  
Restraint. Immediately before radiation exposure or sham irradiation exposure, all 
subject mice were individually placed inside 7.25 cm x 4.10 cm x 4.10 cm well-ventilated 
containment cubes. These cubes did not provide absolute restraint and mice were able to move 
minimally. In minimally restrained mice, time of confinement did not exceed 10 min (restraint-
10 mice). For mice subjected to more sustained restraint, confinement in the containment cube 
was 240 min (restraint-240 mice). Therefore, restraint-10 mice were irradiated while 
simultaneously confined (total confinement/irradiation duration ≤ 10 min). Restraint-240 mice 
were either: 1) irradiated while simultaneously confined (confined/irradiation duration, 10 min) 
then allowed to remain in the containment cube sans irradiation for an additional 230 min (total 
confinement, 240 min) or 2) irradiated while simultaneously confined (total 
confinement/irradiation duration, 240 min). Following any form of restraint, mice were returned 
to their home cage. 
Social exploration. Social exploration was performed as we have previously described 
(17). Social exploration testing was initiated 10 min after irradiation/restraint exposure. At the 
time points indicated a 3-4 wk-old novel conspecific juvenile mouse of the same sex (challenge 
mouse) was introduced into the home cage of the subject mouse. The challenge mouse was 
confined in a 7.62 x 7.62 x 7.62 cm square metal mesh enclosure. Testing duration was 5 min 
and a new challenge mouse was used to test each subject mouse at every time point examined. 
Investigation/exploration was evaluated from the video record and was considered as nose-to-
enclosure contact.  
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 Locomotion. Spontaneous locomotor activity was measured as we have previously 
described (18). Immediately after irradiation/restraint exposure and at the time points indicated 
mice were video recorded in their home cage for 5 min. Movement was quantified using 
EthoVision XT 7 (Noldus Information Technology, Leesburg VA). Parameters examined 
included distance moved (cm) and velocity of movement (cm/s). 
qPCR. Following behavioral testing, mice were sacrificed via CO2 asphyxiation. For 
blood collection, cardiac puncture was executed using a Becton Dickinsin (BD) 26G x 3/8 inch 
needle (Franklin Lakes, NJ). Drawn blood was anti-coagulated in EDTA containing Microtainers 
(BD, Cat No. 365974). After anticoagulation, 0.4 mL of blood was mixed in 1.3 mL of 
RNAlater. Total RNA was extracted using RiboPure Blood Kits per manufacturer’s instructions. 
For brain collection, brains were harvested and either perfused or not perfused (un-perfused) (as 
indicated) with ice cold PBS to remove blood as we have done previously (18). Perfusion studies 
were performed to determine the contribution, if any, of blood based gene transcripts to brain 
biomarker detection. Where indicated cortex, hippocampus, hypothalamus and cerebellum were 
separately dissected from perfused brains as we have done previously (18). In all brain isolations, 
olfactory bulb was not included for study. Total RNA was extracted using a QIAGEN RNeasy 
Lipid Tissue Mini Kit per the manufacturer’s instructions. After all RNA extractions reverse 
transcription was performed with an Applied Biosystem high-capacity cDNA reverse 
transcription kit (Cat No. 4368813). As indicated, qPCR utilized the following TaqMan (Applied 
Biosystems) gene expression primers: IL-1β (Mm99999061_mH), TNF-α (Mm00443258_m1), 
IL-1RA (Mm01337566_m1), activity-regulated cytoskeleton-associated protein (Arc) 
(Mm00479619_m1), IL-6 (Mm01210733_m1), IL-1α (Mm_99999060_m1) and IFN-γ 
(Mm99999071_m1). qPCR was performed on a 7900 HT Fast real-time PCR system (Applied 
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Biosystems) using TaqMan universal PCR master mix (Cat No. 4318157). To normalize gene 
expression, a parallel amplification of endogenous glyceraldehydes-3-phosphate dehydrogenase 
(Mm03302249_g1) was performed. Relative quantitative evaluation of target gene levels was 
performed by comparing ΔCt’s, where Ct was the threshold concentration. 
Statistics. All data are presented as mean ± SEM. Data were analyzed using SAS 9.2 
(SAS Institute, Inc., Cary NC). To test for statistical differences, a one-way or two-way ANOVA 
was used with or without repeated measurements where needed. Tukey’s test was used for post-
hoc pair-wise multiple comparison procedures. Where needed and indicated, raw data was 
transformed to attain normal distribution. Also, where indicated, a Freidman’s two-way ANOVA 
for non-parametric analysis was used when nonparametric data was unable to be transformed to a 
normal distribution. All statistical analysis included testing for time point x dose, restraint x dose 
or perfusion x dose interactions. Statistical significance was denoted at p<0.05. 
 
IV RESULTS 
 
Gamma radiation but not proton radiation reduces mouse locomotor activity. 
Figure.1A shows that restraint-10 mice exposed to 50 or 200 cGy of gamma radiation (44.5 ± 0.1 
cGy/min) had, respectively, a 33.8% and 35.1% reduction in spontaneous distance moved 
(locomotion) 6 h post irradiation compared to sham irradiated mice. Figure.1B shows that mean 
velocity of movement (velocity) was reduced 6 h post irradiation at both 50 and 200 cGy of 
gamma radiation by 34.7% and 35.7%, respectively. When 50 or 200 cGy of gamma radiation 
was delivered at approximately 1/100 the dose rate (0.5 ± 0.01 cGy/min), mouse 
locomotion/velocity was not impacted at 0, 2, 4, 6, 8 or 24 h after irradiation (data not shown). 
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Similarly, when 50 or 200 cGy of proton radiation was used (dose rate of either 0.5 ± 0.01 
cGy/min or 50.0 ± 0.1 cGy/min), mouse locomotion/velocity was not impacted at 0, 2, 4, 6, 8 or 
24 h after irradiation (data not shown). Social exploration was not affected by either 50 or 200 
cGy of gamma or proton radiation (regardless of dose rate) at 0, 2, 4, 6, 8 and 24 post irradiation 
(Table S1). 
Gamma radiation up-regulates gene transcripts for TNF- and Arc in whole brains 6 h 
post irradiation. Figure.2A shows that unperfused and perfused brains from restraint-10 mice 
exposed to 200 cGy of gamma radiation (44.5 ± 0.1 cGy/min) had a 3.2-fold and 2.1-fold 
increase in TNF- gene transcripts, respectively, 6 h post irradiation. Whole brain gene 
transcript expressions for IL-1, IL-1, IL-1RA, IL-6 and IFN-γ were not impacted by gamma 
radiation at this time point. Figure 2B demonstrates that in perfused brains restraint-10 mice 
exposed to 200 cGy of gamma radiation (44.5 ± 0.1 cGy/min) had a 0.37-fold decrease in Arc 6 
h post irradiation.  
Gamma radiation up-regulates gene transcripts for IL-1 and IL-1RA in blood 8 h post 
irradiation. Figure.3A&B show that blood from restraint-10 mice exposed to 200 cGy of gamma 
radiation (44.5 ± 0.1 cGy/min) had a 3.3-fold and 3.3-fold increase in IL-1 and IL-1RA gene 
transcripts, respectively, 8 h post irradiation. Blood gene transcript expressions for IL-1, TNF-
, IL-6, and IFN-γ were not impacted by gamma radiation at this time point or at 4 h post 
gamma irradiation. IL-1 was increased 2.1-fold at 6 h by 200 cGy of gamma radiation (data not 
shown), however, IL-1 IL-1RA, TNF-, IL-6, and IFN-γ were not. Figure.3C&D demonstrate 
that up-regulation of IL-1 and IL-1RA gene transcripts in whole brain at 8 h post gamma 
irradiation are due to blood in the brain. 
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Restraint inhibits the impact of 200 cGy gamma radiation on locomotor activity. Fig.4A 
demonstrates that in restraint-240 mice 200 cGy of radiation (44.5 ± 0.1 cGy/min) increased 
locomotion 4 h post irradiation by 20.3% and 25.4%, respectively, compared to sham irradiated 
restraint-240 mice and restraint-240 mice exposed to 50 cGy of gamma radiation. Likewise, 4 h 
post irradiation velocity was increased in restraint-240 mice exposed to 200 cGy of gamma 
radiation by 25.7% and 45.7%, respectively, compared to sham irradiated restraint-240 mice and 
restraint-240 mice exposed to 50 cGy of gamma radiation. At 6 h post irradiation mice exposed 
to 50 cGy had a 29.2% and 35.3% decrease in locomotion compared to sham and 200 cGy 
gamma irradiated mice and a 29.6% and 35.6% reduction in velocity, respectively. When 
restraint-240 mice were compared to restraint-10 mice, restraint-240 mice exposed to 200 cGy of 
gamma radiation (44.5 ± 0.1 cGy/min) moved 39.5%, 83.5% and 59.1% farther at 4, 6, and 8 h 
post irradiation, respectively (Table S2). Non-irradiated restraint-240 mice and restraint-10 mice 
moved similarly except at the 10 h time point (Table S2).  
Restraint of gamma irradiated mice impacts TNF-, IL-1RA and Arc gene expression 
differentially in cerebral hippocampus, hypothalamus, cortex, and cerebellum at 4, 8, 12 and 
24 h post irradiation. Table 1 shows that when restraint-10 mice and restraint-240 mice were 
exposed to either 50 or 200 cGy of gamma radiation (44.5 ± 0.1 cGy/min) differential gene 
transcript expression of TNF-,IL-1RA and Arc occurred that was dependent on brain region, 
restraint duration and dose of gamma radiation.  
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V DISCUSSION 
 
Near continuous exposure to environmental ionizing radiation of a very low-dose rate is 
omnipresent. With certain occupations and in certain circumstances, dose rate can increase such 
that a modest dose of radiation (200 cGy) is received in a relatively short period of time (>8 hr). 
In humans, these exposures are increasing in frequency (nuclear accidents) and becoming better 
recognized (SPEs). When ionizing radiation doses are significant in duration or energy to cause 
ARS, prodromal stage symptoms of nausea, vomiting and diarrhea (NVD) (3,19) occur 
manifesting within hours (19). Fatigue is either underappreciated or unreported because 
prodromal stage research has focused on NVD as this symptom triad is perceived as predicative 
of severe organ damage and demise (19). In humans, radiation-induced NVD typically requires a 
minimum dose of 70 cGy, although mild symptoms may be observed at doses of 30 cGy (20). 
Radiation-induced fatigue has been best studied in relationship to radiation therapy where loss of 
energy and malaise is a common side effect (21). Serious cancer treatment-associated fatigue, 
however, usually manifests gradually (22) compounding with delivery of repeated fractionated 
doses of 200 cGy that over the course of therapy (up to 8 wks), can deliver up to 80 Gy. In 
general, CNS function is not felt to be impacted at single radiation doses of ≤ 200 cGy (23) and 
if fatigue is documented in a single 100-200 cGy exposure it is usually tallied during the illness 
phase which for a dose ≤ 200 cGy would occur nearly a month post exposure (23). Overall, a 
single isolated exposure of less than ≤ 200 cGy is deemed recoverable without supportive care 
(23) which is underscored by the establishment of 5 cSv (equivalent to 5 cGy of gamma 
radiation) as the annual occupational radiation exposure limit by the Nuclear Regulatory 
Commission (NRC) (24). 
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As delineated above, little work has been performed examining the early impact (<24 h) 
of low-dose (≤ 2 Gy) ionizing radiation on the neuroimmune system. Fig.1 demonstrates that a 
single dose of gamma radiation as low as 50 cGy reduces mouse locomotor activity 6 h after 
exposure. When social exploration was examined at radiation doses of 50 cGy and 200 cGy 
neither dose impaired mouse exploratory behavior (Table S1). These findings indicate that low-
dose ionizing gamma radiation appears to perturb unmotivated behaviors to a greater extent than 
motivated behaviors. Such results are similar to findings we have observed in high-fat diet 
(HFD) fed mice where the HFD state causes a decrease in spontaneous locomotion (18) that is 
not reflected by a loss of social exploration (25). Customarily, strong activators of the 
neuroimmune system like lipopolysaccharide (LPS) induce both locomotor retardation and social 
withdrawal (26). As we have shown, HFD-feeding appears to be a very weak stimulator of CNS 
inflammation (18). Consequently, from a biobehavioral standpoint low-dose radiation is at best a 
very weak immediate activator of neuroimmunity.  
To demonstrate that the irradiation given could activate the neuroimmune system, pro-
inflammatory cytokine gene transcripts were measured in whole brains from mice administered 
both 50 cGy and 200 cGy of gamma radiation. Fig. 2 shows that TNF- is increased 6 h post 
irradiation in mice receiving 200 cGy. When un-perfused brains were compared to perfused 
brains, 50 cGy increased TNF- transcripts in un-perfused brains. To determine if this boost in 
transcripts was due to an increase in blood TNF- transcripts, whole blood TNF- transcripts 
were examined and found to be unaffected by gamma radiation. Blood, however, did show 
significant transcript up-regulation of the inflammatory bioactives IL-1 and IL-1RA 8 h post 
200 cGy gamma irradiation (Fig.3) and these blood transcripts were present in the brain (Fig.3). 
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Taken together these findings indicate that low-dose gamma radiation activates the neuroimmune 
system relatively rapidly. How radiation triggers this response is not clear.  
Previous work with high-dose radiation in mice (15 Gy) has demonstrated that irradiation 
of the body without irradiating the head induces up-regulation of proinflammatory cytokine 
transcripts in the brain (12). This work was designed to support the concept that a stimulated 
peripheral innate immune system could communicate with the brain as is seen with peripheral 
LPS administration (26). Although not designed to test this question, our work is supportive in 
that blood present in the brain contains cells with increased IL-1 gene transcripts. Further 
support for this concept was seen in the proton radiation experiments because proton irradiation 
at both 50 cGy and 200 cGy did not disturb either locomotion or social exploration (data not 
shown, Table S1, respectively). Proton radiation is of higher energy than gamma radiation (27) 
and contributes more significantly to SPEs (6,27). Given this higher energy, we expected proton 
radiation to impact behavior more than gamma radiation. Proton radiation, however, has a 
different linear energy transfer profile than gamma radiation. The Bragg peak for gamma 
radiation is likely more toward the skin surface as opposed to proton radiation where the Bragg 
peak is likely skewed to the interior of the animal. This difference in ionization location further 
supports the potential importance of peripheral immune activation to radiation-induced 
neuroimmune activation. Interestingly, blood also showed an up-regulation of IL-1RA transcripts 
indicating (in conjunction with the IL-1 transcript data noted above) that the IL-1 arm of the 
innate immune system is an early pathway activated by radiation. Organ systems with high 
radiation sensitivity include the hematopoietic system where radiation increases mitochondrial-
dependent reactive oxygen species (ROS) generation (28). Importantly, ROSs have been shown 
recently to stimulate the NALP3 inflammasome (one of three inflammasomes responsible for 
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activation of caspase-1) which is required for the conversion of pro-IL-1 into mature secretable 
IL-1 (29). Curiously, little work has been performed examining radiation and inflammasome 
activation. Given the reduction of locomotion observed after 50 cGy of radiation and the lack of 
pro-inflammatory transcript changes, radiation-dependent triggering of the inflammasome with 
production of mature IL-1 as seen with the NALP3 inflammasome and uric acid (31), seems 
likely. TNF- gene transcript up-regulation may be secondary to the IL-1 signal if that signal is 
significantly robust. 
How pro-inflammatory cytokines induce fatigue is still imprecise. Although CNS IL-1 
(32) and TNF-α are implicated (33-34), the mechanistic connection remains elusive. Some 
believe the indoleamine-2,3-dioxygenase (IDO) pathway may be important (36) because altered 
serotonergic (5-hydroxytryptamine, (5-HT)) neurotransmission is identified in patients with 
chronic fatigue syndrome (36). In addition, pro-inflammatory cytokines, especially TNF-, 
provoke the brain-based IDO pathway to convert the serotonin precursor tryptophan to 
kynurenine which affords production of potential neurotoxic kynurenine metabolites (37-38). 
With radiation-induced fatigue, however, the IDO pathway seems an unlikely player because 
blockade of 5-HT is a key first line defense for the inhibition of radiation-induced nausea and 
vomiting in radiotherapy patients (39) and there is no clear evidence that inhibition of these 
prodromal ARS symptoms with 5-HT antagonists ameliorates subsequent radiation-induced 
fatigue.
 
 
Low dose-rate gamma radiation was also examined and found not to perturb locomotor or 
social exploratory behavior (data not shown, Table S1, respectively). The most likely 
explanations for these observations were that low-dose rate radiation (50 cGy and 200 cGy of 
radiation delivered over 240 min as opposed to 10 min as in Fig.1 (high-dose rate)) did not 
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impart significant energy to activate the neuroimmune system or that the mice in the low-dose 
rate experiments were restrained for 240 min as opposed to 10 min. To investigate these 
possibilities, more prolonged restraint experiments were performed in which mice were delivered 
50 cGy and 200 cGy (both at high-dose rate) during the first 10 min of restraint then left 
restrained for an additional 230 min. Fig.4 reveals that restraint-240 ameliorated the effect of 200 
cGy on locomotion but not that of 50 cGy. Unexpectedly, restraint-240 produced hyper-mobility 
in mice irradiated with 200 cGy suggesting that restraint-240 may sensitize mice to 
biobehavioral stimuli like it does for cutaneous hypersensitivity (40). Importantly, restraint-240 
had no impact on locomotor activity of sham irradiated mice (data not shown) which is 
consistent with the majority of work examining restraint (41). Taken together these findings 
indicate that early radiation-induced alterations in biobehaviors requires a threshold dose rate 
that can be potentially modulated by the stress response. Furthermore, since the bulk of the time 
restrained was spent after irradiation these results point to a radiation priming-like interaction 
which occurs at 200 cGy but not at 50 cGy because the 50 cGy irradiated restraint-240 mice 
behaved like restraint-10 50 cGy irradiated mice (Fig.1).  
In general, the overall impact of restraint tends towards immune suppression (41). Table 
1 shows that immediately after restraint-240 (4 hr post-irradiation) sham irradiated restraint-240 
mice had a decrease in hippocampal, hypothalamic, cortical and cerebellar TNF- transcripts 
compared to sham irradiated restraint-10 mice. 200 cGy irradiation prevented this down-
regulation while 50 cGy had little effect. As time post-irradiation progressed, TNF- transcripts 
increased showing a movement toward resolution by 24 hr post irradiation. Unlike whole brain at 
8 h post irradiation (Fig 3D), brain regions showed region-specific increases in IL-1RA gene 
transcripts. At 8 h post-irradiation, hippocampal IL-1RA gene expression was increased 
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especially in the cortex (Table 1). Peak IL-1RA expression occurred near 12 hrs post-irradiation 
with resolution before 24 hrs. IL-1RA expression patterns somewhat mimicked that of TNF-α 
but were expressed in the brain later and resolved quicker. This pattern fits with a NALP3 
inflammasome driven biobehavioral process (17).  
Finally, activity-regulated cytoskeletal-associated protein (Arc) was up-regulated by 
restraint-240 in the hippocampus as previously reported (42). Arc is an immediate early gene 
induced in hippocampal and parietal neurons following behavioral experiences best tied to 
maintenance of long-term potentiation and spatial memory consolidation (43). Inflammation and 
proinflammatory cytokines, including TNF- are shown to reduce Arc gene transcript 
expression (44). Unexpectedly, restraint-240 led to decreased Arc in the cerebellum. What 
function Arc has in the cerebellum is not clear but it may play a role in cerebellar associative 
learning as evoked in such responses as eyeblink conditioning (45). 200 cGy gamma irradiation 
led to a decrease in whole brain Arc gene transcripts at 6 hr. Brain region analysis (Table 1) 
showed that this effect was transient in that it was not evident at 4 hr or 8 hr post irradiation. At 
24 hr post irradiation (restraint-10 200 cGy), Arc transcripts were reduced in the cortex which 
may fit with post-radiation cognitive deficits that can manifest after whole brain irradiation, 
although acute radiation encephalopathy is rare at doses under 300 cGy (46). Taken together 
these findings indicate that low-dose gamma radiation affects the cortex and hippocampus of 
mice with changes that can last at least 24 hr post-irradiation. Up-regulated TNF- appears 
linked to down-regulated Arc. Since manned space and commercial air travel carry a significant 
risk of SPE exposure in conjunction with physical and psychological stress (extensively studied 
in astronauts (47) and more recently recognized in airline passengers (economy class syndrome 
(48-49))), restraint stress may modulate early radiation-induced fatigue due to brain-based 
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immunosuppression (50). However, this restraint-240-dependent reduction in TNF- gene 
expression is short-lived and cortical TNF- is higher in irradiated restraint-240 animals at 12 hr 
and 24 hr post irradiation when compared to restraint-10 animals. More work is required to 
understand if and/or how early neuroimmune activation contributes to radiation-induced fatigue-
like responses, especially when conjoined to the stress response. 
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VI FIGURES 
A) FIGURE 2.1 
 
 
 
 
 
 
94 
 
Figure 2.1. Gamma radiation but not proton radiation reduces mouse locomotor activity. 
Restraint-10 mice were exposed to 50 or 200 cGy of gamma radiation (44.5 ± 0.1 cGy/min) as 
indicated. Spontaneous locomotor activity and velocity of movement were measured at the time 
points indicated post irradiation. Results are expressed as means ± s.e.m.; n = 8. (A) Distance 
moved (cm): main effects of dose (P < 0.001) and time point (P < 0.001); 6 h time point: P < 
0.05, sham IR v. 50 cGy (1463.8 ± 83.7  v. 968.4 ± 147.6) and sham IR v. 200 cGy (1463.8 ±  
83.7 v. 950.5 ± 117.2). (B) Velocity of movement (cm/s): main effects of dose (P < 0.001) and 
time point (P < 0.001); 6 h time point: P < 0.05, sham IR v. 50 cGy (5.0 ± 0.3 v. 3.3 ± 0.5) and 
sham IR v. 200 cGy (5.0 ± 0.3 v. 3.2 ± 0.4). Bars without a common superscript are different (P 
< 0.05). 
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B) FIGURE 2.2 
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Figure 2.2. Gamma radiation up-regulates gene transcripts for TNF- and Arc in whole 
brain 6 h post irradiation. Restraint-10 mice were exposed to 50 or 200 cGy of gamma 
radiation (44.5 ± 0.1 cGy/min) as indicated. qPCR was used to quantify mRNAs from un-
perfused and perfused whole brains as indicated 6 h post irradiation. Results are expressed as 
relative fold change in mRNA expression (ΔmRNA), means ± s.e.m.; n = 4-6. (A) TNF-α: main 
effect of dose (P < 0.001) and perfusion (P = 0.042); P < 0.05, 200 cGy (unperfused) v. sham IR 
(unperfused), sham IR, 50 cGy (3.205 ± 0.252 v. 1.000 ± 0.166, 1.017 ± 0.286, 1.201 ± 0.241, 
respectively); P < 0.05, 200 cGy v. sham IR (unperfused), sham IR (2.139 ± 0.387 v. 1.000 ± 
0.166, 1.017 ± 0.286, respectively). (B) Arc: main effect of dose (P = 0.003); P < 0.05, 200 cGy 
v. sham IR (unperfused), 50 cGy (unperfused), sham IR (0.370 ± 0.076 v. 1.000 ± 0.239, 0.951 ± 
0.211, 1.074 ± 0.107, respectively).  
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C) FIGURE 2.3 
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Figure 2.3. Gamma radiation up-regulates gene transcripts for IL-1 and IL-1RA in blood 
8 h post irradiation. Restraint-10 mice were exposed to 50 or 200 cGy of gamma radiation 
(44.5 ± 0.1 cGy/min) as indicated. qPCR was used to quantify mRNAs from blood and un-
perfused and perfused whole brains as indicated 8 h post irradiation. Results are expressed as 
relative fold change in mRNA expression (ΔmRNA), means ± s.e.m.; n = 4-6. (A) IL-1β: main 
effect of dose (P < 0.001); P < 0.05, 200 cGy v. sham IR, 50 cGy (3.312 ± 0.468 v. 1.000 ± 
0.182, 0.711 ± 0.254, respectively). (B) 8 h IL-1RA: main effect of dose (P < 0.001); P < 0.05, 
200 cGy v. sham IR, 50 cGy (3.335 ± 0.446 v. 1.000 ± 0.146, 0.690 ± 0.273, respectively). (C) 
IL-1β: main effect of dose (P = 0.006), dose-perfusion interaction (P = 0.002); P < 0.05, 200 cGy 
(unperfused) v. sham IR (unperfused), 50 cGy (unperfused), sham IR , 50 cGy (2.555 ± 0.267 v. 
1.000 ± 0.570, 0.557 ± 0.182, 0.755 ± 0.407, 1.052 ± 0.189, respectively). (D) IL-1RA: main 
effect of dose (P < 0.001); P < 0.05, 200 cGy (unperfused) v. sham IR (unperfused), 50 cGy 
(unperfused), sham IR, 50 cGy (3.013 ± 0.255 v. 1.000 ± 0.531, 0.570 ± 0.244, 0.982 ± 0.488, 
0.935 ± 0.258, respectively); P = 0.009, 200 cGy v. 50 cGy (unperfused) (1.961 ± 0.267 v. 0.570 
± 0.244). Bars without a common superscript are different (P < 0.05). 
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D) FIGURE 2.4 
 
 
 
 
 
 
 
 
 
 
100 
 
Figure 2.4. Restraint-240 inhibits the impact of 200 cGy gamma radiation on locomotor 
activity. Restraint-240 mice were exposed to 50 or 200 cGy of gamma radiation (44.5 ± 0.1 
cGy/min) as indicated. Spontaneous locomotor activity and velocity of movement were 
measured at the time points indicated post irradiation. Results are expressed as means ± s.e.m.; n 
= 8-16. (A) Distance moved (cm): main effects of dose (P = 0.004) and time point (P < 0.001), 
dose-time point interaction (P = 0.036); 4 h time point: P < 0.05, sham IR + restraint-240 v. 200 
cGy + restraint-240 (1559.1 ± 111.5 v. 1955.8 ± 188.1), 50 cGy + restraint-240 v. 200 cGy + 
restraint-240 (1457.3 ± 85.6 v. 1955.8 ± 188.1); 6 h time point: P < 0.05, sham IR + restraint-240 
v. 50 cGy + restraint-240 (1592.9 ± 101.8 v. 1127.7 ± 82.0), 50 cGy + restraint-240 v. 200 cGy + 
restraint-240 (1127.7 ± 82.0 v. 1743.9 ± 151.2). (B) Velocity of movement (cm/s): main effects 
of dose (P =0.003) and time point (P < 0.001), dose-time point interaction (P = 0.013); 4h time 
point: P < 0.05, sham IR + restraint-240 v. 200 cGy + restraint-240 (5.2 ± 0.4 v. 7.0 ± 0.5), 50 
cGy + restraint-240 v. 200 cGy + restraint-240 (4.9 ± 0.3 v. 7.0 ± 0.5); 6 h time point: P < 0.05, 
sham IR + restraint-240 v. 50 cGy + restraint-240 (5.4 ± 0.4 v. 3.8 ± 0.3), 50 cGy + restraint-240 
v. 200 cGy + restraint-240 (3.8 ± 0.3 v. 5.9 ±0.5). Bars without a common superscript are 
different (P < 0.05). 
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CHAPTER THREE 
INDIVIDUALLY VENTILATED CAGES CAUSE CHRONIC LOW-GRADE HYPOXIA 
IMPACTING MICE HEMATOLOGICALLY AND BEHAVIORALLY 
 
I ABSTRACT 
 
 Use of individually ventilated caging (IVC) systems for mouse-based laboratory 
investigation has dramatically increased. We found that without mice present, intra-cage oxygen 
concentration was comparable (21%) between IVC housing and ambient environment caging 
(AEC) that used wire top lids. However, when mice were housed 4-to-a-cage for 1 week, intra-
cage oxygen dropped to 20.5% in IVC housing as compared to 21% for AEC housing. IVC intra-
cage humidity was also elevated relative to AEC housing. Mice raised in IVC housing as 
compared to mice raised in AEC housing had higher RBC mass, hematocrit and hemoglobin 
concentrations. They also had elevated platelet counts but lower white blood cell counts. IVC 
mice relative to AEC mice had increased saccharin preference and increased fluid consumption 
but similar locomotion, food intake, social exploration and novel object recognition when tested 
in an AEC environment. Taken together, these data indicate that ventilated caging systems can 
have a 0.5% reduction from ambient oxygen concentration that is coupled to mouse red blood 
cell indices indicative of chronic exposure to a hypoxia. Importantly, IVC housing can impact 
behavioral testing for depressive-like behavior. 
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II INTRODUCTION 
 
 An important trend in laboratory rodent housing is the use of individually ventilated 
caging (IVC) systems. Purported advantages of IVC systems over conventional, ambient 
environment caging (AEC) (i.e. wire top, open air caging) are allergen and volatile organic 
compound (VOCs) reduction and the ability to increase animal population densities (1-3). In 
animal care/research personnel, allergy to laboratory animals can be as high as 44%, with a 
median time to allergy onset of less than 2 years (4-5). Allergen exposure can originate from 
sources such as urine, fur/pelt, saliva and serum proteins (6), and these allergens can contaminate 
the animal facility in both airborne particulate and fomite forms (7-8). VOCs such as ammonia 
have been identified as causative agents of “sick building syndrome”, with animal care/research 
personnel reporting headache, nausea and fatigue (9). Educational training programs focused on 
personal hygiene and the use of personal protective equipment have reduced the incidence of 
laboratory animal-associated allergies, but with AEC the impact of such interventions has been 
modest (up to 22% of staff still developing allergies) (4). On the other hand, IVC housing has 
been shown to significantly reduce the important mouse-derived human allergen, murine urinary 
protein (7).  
 As we
 
(10) and others
 
(11) have reviewed, pre-experimental conditions are critical to 
rodent-based behavioral testing outcomes. The methodology by which mice are fed, handled and 
housed can dramatically impact a host of behaviors and like-behaviors including those that 
impact locomotion, food intake, learning/memory, social interaction, anxiety and depression 
(12). Little is known concerning how IVC housing affects mouse behaviors when compared to 
AEC housing. The single study published to date showed no effects of IVC housing in mice 
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during plus maze, open field, radial arm maze, acoustic startle or resident intruder tests (2). 
While others have investigated the impact of IVC housing on mouse behavior, these studies 
either used IVC system cages outside of the ventilation unit (13) or were comparing different 
IVC systems to one another (1). Importantly, no clear differences in IVC and AEC housing were 
seen or mechanism for behavioral change presented (1-2,13). In contrast, a cornucopia of data 
exists on the intra-cage microenvironmental differences between IVC and AEC housing with 
special attention paid to carbon dioxide, ammonia vapor and relative humidity (1,3,9,14-15). 
Surprisingly, intra-cage oxygen concentration in IVC housing has been ignored, although it is 
well known that in confined spaces with sealed ventilation systems like commercial airplanes
 
(16), submarines (17) and space stations (18), oxygen concentrations can easily fall below 21%. 
In turn, hypoxia impacts a variety of physiologic functions and bioactives including behavior, as 
we have shown (19) and reviewed (20). In sum, no studies have reported on intra-cage oxygen 
concentration in IVC housing. Therefore, we examined intra-cage oxygen in IVC housing to 
determine its potential relevance to pre-experimental mouse physiology.    
 
III METHODS 
 
 Materials. All reagents and chemicals were purchased from Sigma-Aldrich (St. Louis, 
MO) except as noted. 
 Animals and housing. Animal use was conducted in accordance with institutional 
guidelines for the care and use of laboratory mice. All experimental procedures were approved 
by the University of Illinois at Urbana-Champaign IACUC. All animals were housed in an 
AAALAC accredited laboratory facility as outlined in the Guide for the Care and Use of 
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Laboratory Animals (50). Male C57BL/6J mice, 3 wks of age, were obtained from The Jackson 
Laboratory (Bar Harbor, MN). Prior to shipping, mice had been housed in either IVC or AEC 
conditions by The Jackson Laboratory. Mice were group housed (4 per cage) in standard 
shoebox cages (28 cm x 17 cm x 12.5 cm) with wire top cage lids that were either open to the 
ambient environment (AEC) or attached to a positive-pressure Micro-VENT Mouse individually 
ventilated caging (IVC) system (Allentown, Inc., Allentown, NJ). All mice were allowed water 
and standard rodent chow (NIH-31 7013, Harlan Laboratories, Inc., Indianapolis IN) ad libitum. 
Regardless of housing method used, the room in which the mice resided was environmentally 
controlled on a 12:12 h dark:light cycle (2000 h-0800 h) at a temperature of 72º F (22 º C), 
relative humidity of 45-55% and 10-15 hourly air changes.  
 Oxygen, carbon dioxide, ammonia and humidity. Room and intra-cage air oxygen and 
carbon dioxide were measured using ProOx oxygen and ProCO2 carbon dioxide sensors, 
respectively (Biospherix, Lacona NY). Humidity was measured using a digital hygrometer (Cat 
No. 11-661-18, Fisher Scientific, Pittsburgh PA). Ammonia was measured using a Kwik-Draw 
Sampling Pump (Cat. No. 488543, MSA, Pittsburgh PA) with 5-700 ppm Ammonia-specific 
sampling tubes (Cat. No. CH20501, Dräger Germany). Room and intra-cage air and humidity 
measurements were performed at 1400 h daily for 3 consecutive days. For intra-cage 
measurements, the sensors were located in the food hopper. All cages analyzed contained four 
mice. Measurements were randomized in regard to sensor placement within the room and to cage 
location within the cage racks. 
 Treatments and testing. Mice examined were between 8-12 wks of age and had spent 5-9 
wks in AEC or IVC conditions. AEC mice were housed in AEC conditions (10-15 air changes/h) 
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and then treated and/or tested in AEC conditions. VCS mice were housed in VCS conditions (60 
air changes/h) and then treated and/or tested in AEC conditions. 
 Hematology. After being housed in either AEC or IVC housing, mice were euthanized 
using carbon dioxide. Blood was drawn using post-mortem intracardiac puncture. A total 
approximate volume of 0.6-0.8 mL of blood was obtained from each mouse and placed into two 
separate (0.3-0.5 mL) pediatric EDTA anticoagulation microtainer tubes (Cat No. 365974, 
Becton Dickinson, Franklin Lakes NJ). Complete blood counts (CBC) and differentials were 
performed at Univesity of Illinois Veterinary Diagnotic Laboratory (Urbana IL) on a Abbott 
Diagnostics Cell Dyn 3700 automated hematology cell counter (Abbott Park IL). 
 Body mass and food and water consumption. Immediately prior to testing, mice were 
individually housed in AEC. Body mass and food and water consumption were measured daily at 
1000 h by weight. Food and water consumption were determined from the weight of the water 
bottle plus water and the weight of the food container plus food before and after each 24 h data 
collection period by methods we have previously described (21). Briefly, the daily mass of the 
food or water in their respective containers were subtracted from the previous days mass, to 
determine amount consumed. Cage floors and bedding were carefully checked to account for 
food spillage and potential hoarding. 
 Movement. Movement was assessed by biotelemetry (Mini Mitter, Bend OR) as we have 
previously described (21). In brief, the surgical area (bench top) was cleaned with 70% ethanol. 
Mice were anesthetized via intraperitoneal injection of (80 mg/mL:12 mg/mL) ketamine:xylazine 
(Butler Schein Animal Health, Dublin OH) at 1.5 mL/kg body weight. Immediately preceding 
surgery, mice were injected intraperitoneally with buprenorphine at a dose of 0.05 mg/kg. Fur 
was shaved and the surgical site was aseptically cleaned and prepared using 10% povidone 
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iondine and 70% ethanol in three alternating wipes. Mice were kept on a heating pad during 
surgery and recovery. The abdomen was opened and a sterilized G2 e-mitter (Cat. No. 870-0010-
01; Mini Mitter, Bend OR) was placed in the abdominal cavity along the saggital plane. 3-0 
Vicryl violet braided dissolvable suture material (Cat. No. J393; Ethicon, Inc., Cornelia GA) was 
then passed through the silastic tubing attached to the outer wall of the e-mitter, and the e-mitter 
sutured to the body wall. The skin was then closed with 18/8 acid resistant, antimagnetic 
stainless steel 7.5 mm x 1.75 mm Michel suture clips (Cat. No. 12040-01; Fine Science Tools, 
Foster City CA) using forceps-style application. Immediately post-recovery, mice were 
individually housed in AEC and movement was recorded every hr for 5 days via under-cage ER-
4000 receiver pads (Mini Mitter, Bend OR). Movement was quantified using Vital View data 
acquisition software (Mini Mitter, Bend OR). 
 Saccharin preference testing. Three days prior to saccharin preference testing 
(adaptation phase) mice were singly housed in AEC conditions adapted for two bottle water 
access. Both bottles contained water. After the adaptation phase, fluid bottles (randomized to 
right verses left) contained either water or a 0.4% sodium saccharin solution (Sigma-Aldrich, CN 
4-7839) as we have previously described (22). Fluid consumption was recorded after 24 h. Water 
and saccharin consumption were recorded at 1000 h and determined by weight of the bottle and 
fluids before and after the 24 h data collection period. 
 Social exploration. 24 h prior to testing, AEC and VCS mice were individually housed in 
AEC and VCS conditions, respectively. After 24 h of new home cage acclimation, social 
exploration testing was conducted in AEC conditions, as we have previously described (19). At 
the time points of 0, 2, 4 and 6 h, a 3-4 week-old novel, conspecific juvenile mouse of the same 
sex (challenge mouse) was introduced into the home cage of the subject mouse. The challenge 
 
 
114 
 
mouse was placed in a 7.62 cm x 7.62 cm x 7.62 cm square metal mesh enclosure. Testing 
duration was 5 min and a new challenge mouse was used to test each subject mouse at every time 
point examined. Investigation/exploration was evaluated from the video record by a trained 
observer blinded to the pre-experimental housing conditions. Social exploration was considered 
as nose-to-enclosure contact. Video recording of animal behavior was performed under red light 
using a Sony HDR-XR500V Night Shot capable video camera (San Diego CA). Social 
exploration testing was initiated at 1000 h. 
 Novel object recognition. One hour prior to testing, mice were individually removed 
from their home cage and placed for 5 minutes in a novel arena (home cage-sized with light 
bedding) containing two identical objects (large stainless steel bolts) positioned 10 cm apart at 
the short-side wall end 5 cm from the short side wall and 3.5 cm from the long-side wall. After 
training, mice were returned to their home cage for 1 hr. Testing was initiated by returning mice 
to the testing arena where one of the identical objects (familiar object) was replaced (randomized 
to right or left) by an unfamiliar object (novel object, a 5 mL microfuge tube). Investigative 
behavior was video recorded for 5 min and evaluated from the video record using EthoVision 
XT 7 (Noldus Information Technology, Leesburg VA). Percent investigation was calculated by 
dividing the time spent examining each object by the total time spent investigating both objects. 
Testing occurred 4.5 h after the beginning of the dark cycle (1200 h). Video recording of animal 
behavior was performed under red light using a Night Shot capable video camera. 
 Statistics. All data are presented as mean ± SEM. Data were analyzed using SAS 9.2 
(SAS Institute, Inc., Cary NC). To test for statistical differences, a one-way or two-way ANOVA 
was used with or without repeated measurements where needed. Tukey’s test was used for post-
hoc pair-wise multiple comparison procedures. All statistical analysis included testing for time 
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point x housing type interactions, where appropriate. Statistical significance was denoted at 
p<0.05. 
 
IV RESULTS 
 
 Air oxygen concentration is reduced in IVC housing when compared to AEC housing. 
Table 1 demonstrates that intra-cage air oxygen in IVC housing was 2.5% less than in AEC 
housing when mice were housed 4 per cage. Table 2 shows that intra-cage humidity was 
increased 44% in IVC housing compared to AEC housing when mice were housed 4 per cage. 
Carbon dioxide and ammonia concentrations were comparable between IVC and AEC housing 
(data not shown). 
 IVC mice show hematologic evidence of chronic exposure to low-grade hypoxia. Table 
3 shows that IVC mice when compared to AEC mice had a 9.7%, 8.6% and 8.8% increase in 
RBC number, hemoglobin and hematocrit, respectively. Table 4 demonstrates that leukocytes 
and platelets were decreased 37.5% and increased 16.7%, respectively in IVC mice when 
compared to AEC mice.  
 IVC mice consume less water after transfer to an AEC environment. Table 5 shows that 
IVC mice during their first 24 h of individual housing in an AEC environment drink 15.1% less 
water compared to AEC mice transferred to individual housing in AEC conditions. Percent daily 
changes in body weight and food intake were not impacted by this housing switch. After 48 hr in 
an AEC environment, IVC mice water intake was comparable to AEC mice (Table 5). 
 IVC mice have an increased preference for saccharin but no change in locomotion, 
social exploration or novel object recognition. Fig.1A shows that IVC mice had a 10.9% 
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increase in saccharin preference compared to AEC mice (81.9 ± 3.6 v. 90.8 ± 1.2). This elevation 
was coupled to a 21.5% increase in total fluid consumption (water + saccharin solution) (9.1 ± 
0.7 v. 11.1 ± 0.5) (Fig.1B). Table 6 demonstrates that, after implanting intraperitoneal 
biotelemetry probes, mouse movement for both AEC and IVC mice took 48 h to stabilize. Social 
exploration and novel object recognition was comparable between AEC and IVC mice (data not 
shown). 
 
V DISCUSSION 
 
 To our knowledge, this is the first study to report a significant reduction in oxygen within 
IVC housing when compared to AEC housing (Table 1). In addition, the mean relative humidity 
was higher in IVC as compared to AEC housing consistent with previous reports (Table 2) (15). 
An expected physiologic response to reduced oxygen is increased red blood cell (RBC) mass and 
blood hemoglobin (23-24). Table 3 reflects such changes because IVC mice, compared to AEC 
mice, showed an increase in hematocrit as well as RBC and hemaglobin concentrations. Studies 
examining RBC physiology in mice at altitude have been performed with increases in hematocrit 
and RBC/hemoglobin concentrations seen (25). It is important to note that IVC housing is a low-
grade hypoxia equivalent to an altitude of 90 m and normobaric (760 mm Hg) (26). At an 
altitude of 1760 m, the oxygen concentration is 84% that of sea level and the atmospheric 
condition is hypobaric (614 mm Hg) (26-27). In general, atmospheric pressure and inspired 
oxygen percentage decrease in a near linear fashion from 100% at sea level, with 50% of sea 
level oxygen available at 5500 m and 30% of sea level oxygen available at 8900 m (the peak of 
Mt Everest) (26).
 
The likely mechanism for the increase in blood oxygen carrying capacity seen 
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in mice and men exposed to altitude is hypoxia-dependent up-regulation of erythropoietin which 
has been demonstrated in naturally occurring hypoxia (living at altitude (24)) and in 
experimentally-induced hypoxia (28).  
 Interestingly, total leukocytes were lower in IVC mice compared to AEC mice (Table 4). 
This drop in white cell count was not associated with a shift in leukocyte relative percentages. 
The reason for a lower white cell count in the face of a higher RBC mass is not clear. In humans, 
leukocyte numbers measured at sea level do not change significantly when re-measured after 8 
months at an altitude of 3550 m (29). Unfortunately, data for leukocyte counts in mice housed at 
altitude is lacking. A possible cause of the lower WBC counts seen in IVC mice is the relative 
lack of ammonia in the IVC microenviorment (1). Von Borell et al. (30) has shown that pigs 
exposed to 35-50 ppm atmospheric ammonia for 19 days have increased absolute monocyte, 
lymphocyte and neutrophils counts. We, however, did not observe measurable ammonia in either 
IVC or AEC housing.  
 Platelet counts were higher in IVC mice relative to AEC mice. Previous work has 
demonstrated that humans exposed to 12.8% oxygen (normobaric) for 3 h had increased platelet 
counts that persisted for 24 h post-treatment (31). Mice exposed to 5.5-6.5% oxygen 
(normobaric) for 1-7 days had elevated platelet counts for the first 3 d of exposure before 
returning to normoxic control levels at day 4 and 5 of hypoxia exposure. Day 6 and 7 of hypoxia 
exposure showed significantly lowered platelet counts compared to normoxic control mice (32). 
Mechanisms of hypoxia-dependent thrombocytosis may potentially be gleaned from obesity 
research in that the obese state is associated with both elevated platelet counts in human females 
(33) and tissue hypoxia in animals (34). Bioactives implicated in thrombocytosis include leptin, 
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IL-6 and IL-1 which have all been shown to be increased in the obese state (35-36) and the 
hypoxic state (19,37-38).  
 We have previously shown that acute hypoxia leads to sickness behaviors in mice via a 
mechanism reliant on IL-1 (19,38). However, unlike mice exposed to 8% oxygen for 2 h, IVC 
mice had comparable locomotor activity, food intake, social exploration and novel object 
recognition as AEC mice. These findings are consistent with those of Mineu et al. (2), who 
showed that aggression, learning/memory and anxiety-like behaviors were unaffected by IVC 
housing. Water consumption and saccharin preference were significantly different between IVC 
and AEC mice (Table 5 and Fig.1). IVC mice had an enhanced preference for saccharin 
suggesting increased hedonism. This finding was unexpected due to human data showing an 
association between living at altitude and a higher rate of suicide (39-40). In humans, studies 
examining mood and cognitive function at altitude have been performed in locations between 
3,000 m and 6,000 m above sea level (41-42). Acute mood disturbances and reduced 
performance of tasks have been reported in some individuals at altitudes as low as 3,000 m (42). 
Most persons will report impaired function at 5,000 m which has an oxygen concentration of 
58% that of sea level (26,42). With ascent to altitude, a euphoric phase often occurs prior to the 
onset of mood depression (41-42). Additional evidence for the subjective feeling of euphoria can 
be found in reports dealing with “the choking game,” which is a potentially life-threatening ritual 
used among adolescents around the world, which essentially consists of compression of the 
carotid arteries while holding one’s breath (43). Since our mice were chronically exposed to low-
grade hypoxia and then tested in a normoxic environment, the physiology modeled may be more 
akin to hyperoxygenation. Hyperoxygenation has been shown to increase memory and learning 
in rodent models of traumatic brain injury (44). However, the role of hyperoxygenation in 
 
 
119 
 
memory and learning remains clouded, as studies in rodent models of Alzheimer’s Disease show 
it leads to cognitive impairment (45). In humans, fatigue is a reported complication of oxygen 
therapy, especially, hyperbaic oxygen therapy (46). The impact of increased oxygen on persons 
without hypercapnic respiratory problems are not known. Hyperventilation is associated with 
anxietal symptoms in humans (47) which are thought to be related to the impact of respiratory 
alkalosis on the CNS (48). Increasing the concentration of inhaled carbon dioxide by breathing 
into a paper bag is an effective way of decreasing anxiety associated with hyperventation while 
raising blood pCO2 and, hence blood pH (49). Unfortunately, no work has been performed on 
depressive-like behaviors in mice associated with hyperoxygenation. 
In sum, our findings indicate that IVC-housed mice could be used to model chronic low-
grade hypoxia. Use of IVC-housing without a diligent examination of its impact on RBC mass 
and oxygen carrying capacity, is unadvised for those researchers investigating diseases tied to the 
hematopoietic system. How changes in oxygen effect mood is not understood but given the 
findings here warrants further study. 
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VI FIGURES 
A) TABLE 3.1 
 
 
B) TABLE 3.2 
 
 
 
 
 
 
Table 3.1 
Oxygen (O2) percentages in ambient room air and within AEC or IVC housing conditions. 
 AEC IVC 
Ambient (room) O2 (%): 20.98 (0.03)
a -20.97 (0.05)a* 
Cage O2 (%): 20.98 (0.03)
a -20.43 (0.05)b* 
O2 percentage change (%): 00.00 (0.00) 0-2.54 (0.10)* 
Results are expressed as mean (s.e.m.), n=4-6/housing condition. *P < 0.0001, AEC O2 
percentage change (%) v. IVC O2 percentage change (%). Results without a common 
superscript letter are significantly different (P < 0.0001). 
 
Table 3.2 
Relative humidity (RH) percentages in ambient room air and within AEC or IVC housing 
conditions. 
 AEC IVC 
Ambient (room) RH (%): 26.67 (0.11)a 32.65 (0.75)b* 
Cage RH (%): 26.87 (0.09)a 47.28 (1.32)c* 
RH percentage change (%): 00.75 (0.37)a 44.87 (4.18)*x 
Results are expressed as mean (s.e.m.), n=4-6/housing condition. *P < 0.0001, AEC RH 
percentage change (%) v. IVC RH percentage change (%). Results without a common 
superscript letter are significantly different (P < 0.0001). 
 
 
 
121 
 
C) TABLE 3.3 
 
D) TABLE 3.4 
 
 
Table 3.3 
Red blood cell (RBC) counts and related RBC parameters from AEC- and IVC-housed mouse 
blood draws. 
 AEC IVC 
Red blood cells (M/μL): 08.46 (0.09)a 9.28 (0.07)b 
Hemoglobin (g/dL): 12.78 (0.13)a 13.88 (0.06)b 
Hematocrit (%): 41.57 (0.39)a 45.23 (0.31)b 
Mean cell volume (fL): 49.02 (0.15)x 48.80 (0.31)x 
Mean cell hemoglobin (pg): 15.08 (0.11)x 14.95 (0.10)x 
Mean cell hemoglobin concentration (g/dL): 30.75 (0.20)x 30.68 (0.10)x 
RBC distribution width (%): 18.55 (0.56)x 18.58 (0.26)x 
Results are expressed as mean (s.e.m.), n=4-6/housing condition. Results within rows 
without a common superscript letter are significantly different (P < 0.05). 
 
Table 3.4 
Leukocyte counts, differentials and platelet count/volume from AEC- and IVC-housed mouse 
whole blood draws. 
 AEC IVC 
Leuckocytes (K/μL): 002.99 (0.34)a0 01.87 (0.17)b 
Neutrophils (%): 007.14 (1.02)x0 10.63 (1.64)x 
Lymphocytes (%): 080.82 (6.12)x0 81.18 (1.99) 
Monocytes (%): 008.43 (4.91)x0 05.17 (1.96) 
Eosinophils (%): 000.96 (0.25)x0 00.97 (0.25) 
Basophils (%): 002.64 (0.90)x0 02.07 (0.48) 
Platelets (K/μL): 890.83 (37.30)a 1039.30 (27.35)b 
Mean platelet volume (fL): 06.47 (0.14)x 006.26 (0.09)x 
Results are expressed as mean (s.e.m.), n=4-6/housing condition. Results within rows 
without a common superscript letter are significantly different (P < 0.05). 
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E) TABLE 3.5 
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F) FIGURE 3.1 
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Figure 3.1. IVC mice show an increased preference for saccharin and consume more total 
fluid than AEC mice. (A) Results are expressed as percent saccharin consumed, means ± s.e.m., 
n = 12. Bars without a common superscript are significantly different (P < 0.05, AEC v IVC: 
81.887 ± 3.600 v. 90.798 ± 1.235). (B) Results are expressed as total fluid consumed in grams, 
means ± SEM: n = 12. Bars without a common superscript are significantly different (P < 0.05, 
AEC v. IVC: 9.112 ± 0.678 v. 11.073 ± 0.488).  
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